<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">7DRMSHyvpvwrCxvz67MhJVq</article-id>
      <article-id pub-id-type="other">00018</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2010000400018</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(10)09400418</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2010000400018</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos de Revis&#227;o</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Doen&#231;a arterial coronariana, exerc&#237;cio f&#237;sico e estresse oxidativo</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pinho</surname>
            <given-names>Ricardo Aurino de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ara&#250;jo</surname>
            <given-names>Mar&#237;lia Costa de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ghisi</surname>
            <given-names>Gabriela Lima de Melo</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Benetti</surname>
            <given-names>Magnus</given-names>
          </name>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="state">Santa Catarina</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade do Extremo Sul Catarinense</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Crici&#250;ma</named-content>
          <named-content content-type="state">Santa Catarina</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade do Estado de Santa Catarina</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>04</month>
        <year>2010</year>
      </pub-date>
      <volume>94</volume>
      <issue>4</issue>
      <fpage>549</fpage>
      <lpage>555</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>10</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>03</day>
          <month>03</month>
          <year>2009</year>
        </date>
        <date date-type="rev-recd">
          <day>19</day>
          <month>01</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>As doen&#231;as cardiovasculares (DCV) lideram os &#237;ndices de morbidade e mortalidade no Brasil e no mundo, sendo a doen&#231;a arterial coronariana (DAC) a causa de um grande n&#250;mero de mortes e de gastos em assist&#234;ncia m&#233;dica. In&#250;meros fatores de risco para a DAC est&#227;o diretamente relacionados &#224; disfun&#231;&#227;o endotelial. A presen&#231;a desses fatores de risco induz a diminui&#231;&#227;o da biodisponibilidade de &#243;xido n&#237;trico (NO), o aumento da forma&#231;&#227;o de radicais livres (RL) e o aumento da atividade endotelial. Essas mudan&#231;as podem levar a uma capacidade vasodilatadora prejudicada. In&#250;meras interven&#231;&#245;es s&#227;o realizadas no tratamento da DAC, incluindo agentes farmacol&#243;gicos, mudan&#231;a nos h&#225;bitos alimentares, suplementa&#231;&#227;o nutricional e exerc&#237;cio f&#237;sico regular, cujos efeitos ben&#233;ficos sobre a fun&#231;&#227;o endotelial v&#234;m sendo demonstrados em experimentos com animais e humanos. Entretanto, a literatura ainda &#233; controversa quanto &#224; intensidade de esfor&#231;o necess&#225;ria para provocar altera&#231;&#245;es protetoras significativas na fun&#231;&#227;o endotelial. Da mesma forma, exerc&#237;cios intensos est&#227;o tamb&#233;m relacionados ao aumento no consumo de oxig&#234;nio e ao consequente aumento na forma&#231;&#227;o de radicais livres de oxig&#234;nio (RLO).</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Doen&#231;a da art&#233;ria coronariana</kwd>
        <kwd>exerc&#237;cio</kwd>
        <kwd>endot&#233;lio vascular</kwd>
        <kwd>radicais livres</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>22</day>
        <month>09</month>
        <year>2010</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>ARTIGO DE REVIS&#195;O</bold>
    </p>
    <p>Doen&#231;a arterial coronariana, exerc&#237;cio f&#237;sico e estresse oxidativo </p>
    <p>
      <bold>Ricardo Aurino de Pinho<sup>I</sup>; Mar&#237;lia Costa de Ara&#250;jo<sup>I</sup>; Gabriela Lima de Melo Ghisi<sup>II</sup>; Magnus Benetti<sup>II</sup></bold>
    </p>
    <p><sup>I</sup>Universidade do Extremo Sul Catarinense </p>
    <p><sup>II</sup>Universidade do Estado de Santa Catarina, Crici&#250;ma, SC - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="linkcorresp">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p>As doen&#231;as cardiovasculares (DCV) lideram os &#237;ndices de morbidade e mortalidade no Brasil e no mundo, sendo a doen&#231;a arterial coronariana (DAC) a causa de um grande n&#250;mero de mortes e de gastos em assist&#234;ncia m&#233;dica. In&#250;meros fatores de risco para a DAC est&#227;o diretamente relacionados &#224; disfun&#231;&#227;o endotelial. A presen&#231;a desses fatores de risco induz a diminui&#231;&#227;o da biodisponibilidade de &#243;xido n&#237;trico (NO), o aumento da forma&#231;&#227;o de radicais livres (RL) e o aumento da atividade endotelial. Essas mudan&#231;as podem levar a uma capacidade vasodilatadora prejudicada. In&#250;meras interven&#231;&#245;es s&#227;o realizadas no tratamento da DAC, incluindo agentes farmacol&#243;gicos, mudan&#231;a nos h&#225;bitos alimentares, suplementa&#231;&#227;o nutricional e exerc&#237;cio f&#237;sico regular, cujos efeitos ben&#233;ficos sobre a fun&#231;&#227;o endotelial v&#234;m sendo demonstrados em experimentos com animais e humanos. Entretanto, a literatura ainda &#233; controversa quanto &#224; intensidade de esfor&#231;o necess&#225;ria para provocar altera&#231;&#245;es protetoras significativas na fun&#231;&#227;o endotelial. Da mesma forma, exerc&#237;cios intensos est&#227;o tamb&#233;m relacionados ao aumento no consumo de oxig&#234;nio e ao consequente aumento na forma&#231;&#227;o de radicais livres de oxig&#234;nio (RLO).</p>
    <p><bold>Palavras-chave:</bold> Doen&#231;a da art&#233;ria coronariana, exerc&#237;cio, endot&#233;lio vascular, radicais livres. </p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A doen&#231;a arterial coronariana (DAC) caracteriza-se pela insufici&#234;ncia de irriga&#231;&#227;o sangu&#237;nea no cora&#231;&#227;o por meio das art&#233;rias coron&#225;rias. Est&#225; diretamente relacionada ao grau de obstru&#231;&#227;o do fluxo sangu&#237;neo pelas placas ateroscler&#243;ticas, resultando em estreitamento das art&#233;rias coron&#225;rias (estenose), o qual, devido &#224; redu&#231;&#227;o do fluxo sangu&#237;neo coronariano<sup>1</sup>, diminui a chegada do oxig&#234;nio ao cora&#231;&#227;o.</p>
    <p>As doen&#231;as cardiovasculares (DCV) lideram os &#237;ndices de morbidade e mortalidade no Brasil e no mundo, sendo a DAC a causa de um grande n&#250;mero de mortes e de gastos em assist&#234;ncia m&#233;dica<sup>2,3</sup>. No Brasil, segundo a S&#237;ntese de Indicadores Sociais de 2002, realizada pelo Instituto Brasileiro de Geografia e Estat&#237;stica (IBGE), as DCV se destacam como a principal causa de mortes no pa&#237;s (28,8% para homens e 36,9% para mulheres), em todas as regi&#245;es e estados. A regi&#227;o Sul e o estado do Rio Grande do Sul, em particular, registram as maiores propor&#231;&#245;es, sendo respons&#225;veis por 40% das mortes de mulheres<sup>3</sup>. O fumo, a obesidade, o <italic>diabetes mellitus</italic>, a hipertens&#227;o, os n&#237;veis elevados de colesterol, a hist&#243;ria familiar de DAC e a falta de exerc&#237;cios aumentam o risco da doen&#231;a<sup>1,2</sup>.</p>
    <p>Hermann e Lerman<sup>4</sup> sugerem que v&#225;rios fatores de risco para a DAC est&#227;o diretamente relacionados &#224; disfun&#231;&#227;o endotelial. A presen&#231;a desses fatores de risco causa um grande n&#250;mero de mudan&#231;as prejudiciais &#224; biologia vascular, incluindo a diminui&#231;&#227;o da biodisponibilidade de &#243;xido n&#237;trico (NO), aumento da forma&#231;&#227;o de radicais livres (RL) e aumento da atividade endotelial. Essas mudan&#231;as podem levar a uma capacidade vasodilatadora prejudicada<sup>5-7</sup>.</p>
    <p>In&#250;meras interven&#231;&#245;es s&#227;o realizadas no tratamento da DAC, incluindo agentes farmacol&#243;gicos, mudan&#231;a nos h&#225;bitos alimentares, suplementa&#231;&#227;o nutricional e exerc&#237;cio f&#237;sico regular.</p>
    <p>O exerc&#237;cio f&#237;sico leve a moderado, realizado regularmente, &#233; recomendado para a manuten&#231;&#227;o da sa&#250;de e preven&#231;&#227;o de in&#250;meras doen&#231;as. Tamb&#233;m reduz a produ&#231;&#227;o de oxidantes e a ocorr&#234;ncia de danos oxidativos, melhorando o sistema de defesa antioxidante e aumentando a resist&#234;ncia dos &#243;rg&#227;os e tecidos contra a a&#231;&#227;o delet&#233;ria dos RL<sup>8</sup>. No entanto, alguns estudos<sup>9-11 </sup>apresentam evid&#234;ncias de que o exerc&#237;cio f&#237;sico, principalmente os mais intensos, est&#225; associado tanto a danos musculares quanto &#224; produ&#231;&#227;o elevada de RL.</p>
    <p>Os efeitos ben&#233;ficos do exerc&#237;cio f&#237;sico regular sobre a fun&#231;&#227;o endotelial v&#234;m sendo demonstrados em experimentos com animais e humanos<sup>12</sup>. Entretanto, a literatura ainda &#233; controversa quanto &#224; intensidade de esfor&#231;o necess&#225;ria para provocar altera&#231;&#245;es protetoras significativas na fun&#231;&#227;o endotelial. Segundo Farsifar e cols.<sup>13 </sup>e Wisl&#248;ff e cols.<sup>14</sup>, exerc&#237;cios agudos e intensos apresentam significativa e r&#225;pida resposta na fun&#231;&#227;o endotelial. Todavia, estudos apontam que exerc&#237;cios intensos est&#227;o tamb&#233;m relacionados ao aumento no consumo de oxig&#234;nio e ao consequente aumento na forma&#231;&#227;o de RL em m&#250;sculo card&#237;aco e esquel&#233;tico<sup>10,11,15</sup>.</p>
    <p>Dessa forma, esta revis&#227;o busca abordar a disfun&#231;&#227;o endotelial envolvida na g&#234;nese da DAC, enfocando o papel do endot&#233;lio vascular, bem como a import&#226;ncia do exerc&#237;cio f&#237;sico sobre a fun&#231;&#227;o endotelial e dos par&#226;metros de estresse oxidativo na DAC.</p>
    <p>
      <bold>Fun&#231;&#227;o endotelial e aterosclerose</bold>
    </p>
    <p>Sabe-se bem que as caracter&#237;sticas funcionais das art&#233;rias coron&#225;rias s&#227;o determinadas pelas c&#233;lulas endoteliais, c&#233;lulas do m&#250;sculo liso vascular e de elementos do tecido conectivo nas paredes arteriais. O m&#250;sculo vascular &#233; o final do caminho habitual para ativar o controle do di&#226;metro das art&#233;rias e, portanto, da resist&#234;ncia vascular<sup>16-18</sup>.</p>
    <p>Tradicionalmente, considerava-se que o papel do endot&#233;lio era, sobretudo, de barreira seletiva para a difus&#227;o de macromol&#233;culas da luz dos vasos sangu&#237;neos para o espa&#231;o intersticial. Durante os &#250;ltimos 20 anos, no entanto, foram definidas muitas outras fun&#231;&#245;es para o endot&#233;lio, como regula&#231;&#227;o do t&#244;nus vagal<sup>16</sup>, modula&#231;&#227;o da inflama&#231;&#227;o, promo&#231;&#227;o e inibi&#231;&#227;o do crescimento neovascular<sup>17</sup> e modula&#231;&#227;o da agrega&#231;&#227;o plaquet&#225;ria e da coagula&#231;&#227;o<sup>16-18</sup>. Em adi&#231;&#227;o, o endot&#233;lio &#233; respons&#225;vel pela s&#237;ntese de fatores vasoconstritores e vasodilatadores, sendo o NO um dos fatores relaxantes de maior import&#226;ncia<sup>19,20</sup>, derivados do endot&#233;lio.</p>
    <p>Em condi&#231;&#245;es basais, em indiv&#237;duos sadios, h&#225; t&#244;nus vasodilatador moderado e constante, causado pelo NO endotelial se difundindo para as c&#233;lulas da musculatura lisa vascular; se a forma&#231;&#227;o basal de NO cessa, aparecer&#225; vasoconstri&#231;&#227;o. A baixa forma&#231;&#227;o de NO (em v&#225;rias doen&#231;as vascu lares) reduz a perfus&#227;o tecidual e promove a forma&#231;&#227;o de trombo, enquanto a alta forma&#231;&#227;o de NO produz vasodilata&#231;&#227;o pronunciada e choque<sup>21</sup>.</p>
    <p>Diversas doen&#231;as, como as dislipidemias, a aterosclerose e a hipertens&#227;o arterial sist&#234;mica (HAS) apresentam, em sua g&#234;nese e/ou em seus mecanismos fisiopatol&#243;gicos, altera&#231;&#245;es na fun&#231;&#227;o endotelial. Assim, a disfun&#231;&#227;o endotelial, caracterizada por menor produ&#231;&#227;o e/ou biodisponibilidade de NO, &#233; um dos fatores que contribuem para o aparecimento das DCV<sup>20,22</sup>.</p>
    <p>O entendimento da g&#234;nese e progress&#227;o da aterosclerose tem sido fortemente esclarecedor na &#250;ltima d&#233;cada. Em meados da d&#233;cada de 1970, Ross e Glomaser<sup>23</sup> sugeriram que a aterosclerose coron&#225;ria come&#231;a com uma inj&#250;ria na parede arterial, levando &#224; desnuda&#231;&#227;o do endot&#233;lio ou &#224; descama&#231;&#227;o do revestimento endotelial da art&#233;ria. Complementando esta hip&#243;tese, evid&#234;ncias recentes sugerem que mesmo as cl&#225;ssicas manchas de gordura - a primeira les&#227;o comum na inf&#226;ncia - s&#227;o uma les&#227;o inflamat&#243;ria constitu&#237;da de macr&#243;fagos, mon&#243;citos derivados e linf&#243;citos -T<sup>24</sup>.</p>
    <p>Em pessoas sem aterosclerose, o efeito predominante da ativa&#231;&#227;o endotelial e libera&#231;&#227;o de NO &#233; a vasodilata&#231;&#227;o. O ferimento endotelial e a desnuda&#231;&#227;o resultam na disfun&#231;&#227;o (vasoconstri&#231;&#227;o paradoxal em resposta a agentes vasodilatadores), que parece ser o evento inicial para o desenvolvimento da aterosclerose. A disfun&#231;&#227;o endotelial precede a apar&#234;ncia f&#237;sica da aterosclerose na angiografia<sup>25</sup>. O conhecimento crescente de que o di&#226;metro do l&#250;men das coron&#225;rias do epic&#225;rdio, dos vasos de resist&#234;ncia e das art&#233;rias perif&#233;ricas maiores &#233;oalterado, em resposta aos fatores fluxo-mediado e agonista-mediado (NO e endot&#233;lio-1), tem contribu&#237;do para o entendimento da ateroscleros. Ludmer e cols.<sup>26</sup> e El-Tamimi e cols.<sup>27</sup> primeiro observaram uma vasoconstri&#231;&#227;o parad&#243;xica de segmentos ateroscler&#243;ticos de art&#233;rias coron&#225;rias em resposta &#224; infus&#227;o de acetilcolina.</p>
    <p>Percebe-se, portanto, que o dano endotelial e sua disfun&#231;&#227;o s&#227;o eventos iniciais da aterosclerose. Adicionalmente, a disfun&#231;&#227;o endotelial &#233; tamb&#233;m reconhecida como fator importante em s&#237;ndrome coronariana aguda (SCA)<sup>7,18,28</sup>. Rozanski e cols.<sup>29</sup> compararam a resposta do fluxo sangu&#237;neo perif&#233;rico em 57 pacientes com doen&#231;a coronariana e em 50 sujeitos aparentemente saud&#225;veis com controle. Os dois grupos foram submetidos a um exerc&#237;cio f&#237;sico em esteira ergom&#233;trica, e os resultados revelaram n&#227;o haver nenhuma manifesta&#231;&#227;o de vasodilata&#231;&#227;o induzida pelo exerc&#237;cio no grupo controle. Em contrapartida, 53% dos sujeitos com doen&#231;a coronariana demonstraram vasoconstri&#231;&#227;o progressiva.</p>
    <p>O endot&#233;lio, quando agredido por fatores de risco, perde progressivamente sua fun&#231;&#227;o fisiol&#243;gica de prote&#231;&#227;o, passando a ser fonte de elementos que participam da progress&#227;o da aterosclerose. Esses danos ou ativa&#231;&#227;o do endot&#233;lio modificam fun&#231;&#245;es regulat&#243;rias, resultando na disfun&#231;&#227;o endotelial, alterando a resposta vasodilatadora e reduzindo a atividade antitromb&#243;tica, ocasionando altera&#231;&#245;es estruturais e, obviamente, dano vascular<sup>6,7,30,31</sup>.</p>
    <p>Portanto, a aterosclerose &#233; o prot&#243;tipo da doen&#231;a caracterizada, em todas as suas fases, por uma disfun&#231;&#227;o endotelial, que &#233; definida como uma oferta insuficiente de NO, causadora de estresse oxidativo, inflama&#231;&#227;o, eros&#227;o e vasoconstri&#231;&#227;o<sup>4</sup>.</p>
    <p>Entre os fatores que causam dano ao endot&#233;lio, as esp&#233;cies reativas de oxig&#234;nio (ERO) e as esp&#233;cies reativas (ERN) - especificamente as derivadas do NO -, s&#227;o cada vez mais reconhecidas como as principais respons&#225;veis por comprometer a fun&#231;&#227;o endotelial celular e por sua implica&#231;&#227;o na aterog&#234;nese<sup>7</sup>.</p>
    <p>
      <bold>Esp&#233;cies reativas de oxig&#234;nio e estresse oxidativo na DAC</bold>
    </p>
    <p>Sob condi&#231;&#245;es fisiol&#243;gicas normais, a maioria das ERO &#233; produzida na cadeia respirat&#243;ria mitocondrial, onde de 2% a 5% dos el&#233;trons s&#227;o desviados para a produ&#231;&#227;o de RL. Adicionalmente, as ERO podem ser geradas em outros eventos bioqu&#237;micos na c&#233;lula, como, por exemplo, em processos inflamat&#243;rios, no catabolismo de &#225;cidos graxos, na degrada&#231;&#227;o da xantina a &#225;cido &#250;rico e auto-oxida&#231;&#227;o de catecolaminas<sup>32</sup>. Embora esses processos sejam normais para a vida das c&#233;lulas, a produ&#231;&#227;o excessiva de ERO pode provocar danos a biomol&#233;culas (como &#225;cidos nucleicos, prote&#237;nas e lip&#237;dios) os quais, em grande extens&#227;o, podem levar &#224; morte celular<sup>32</sup>.</p>
    <p>A produ&#231;&#227;o de RL nem sempre &#233; prejudicial ao organismo, pelo contr&#225;rio - &#233; necess&#225;ria em v&#225;rios processos biol&#243;gicos, como sinaliza&#231;&#227;o celular, contra&#231;&#227;o muscular e sistema imune<sup>33</sup>. Por exemplo, quando as c&#233;lulas s&#227;o agredidas por algum agente estressor (que tamb&#233;m pode ser RL), elas acabam produzindo RL para combater esses agentes. O grande problema &#233; que, quando os n&#237;veis totais gerados de RL forem maiores que a capacidade de defesa, podem ocorrer danos celulares significativos.</p>
    <p>O aumento do estresse oxidativo pode contribuir para a patog&#234;nese de doen&#231;as cardiovasculares<sup>2,6,7</sup>. Estudos cl&#237;nicos experimentais t&#234;m sugerido que essas doen&#231;as est&#227;o associadas ao aumento da forma&#231;&#227;o de radicais livres e &#224; redu&#231;&#227;o das defesas antioxidantes<sup>2,6,34</sup>.</p>
    <p>Na parede vascular, diferentes oxidantes podem se originar de fontes celulares e extracelulares e de rotas enzim&#225;ticas e n&#227;o enzim&#225;ticas. As principais fontes de RL na parede vascular inflamada, com aceit&#225;vel relev&#226;ncia fisiol&#243;gica nas DCV, s&#227;o: NADPH oxidase, &#243;xido n&#237;trico sintase endotelial (eNOS) desacoplada e &#243;xido n&#237;trico sintase induz&#237;vel (iNOS); mieloperoxidase, xantina oxidase (XO), lipoxigenase/ciclooxigenase e cadeia respirat&#243;ria/fosforila&#231;&#227;o oxidativa<sup>2,7,35</sup>.</p>
    <p>Atualmente, o mais importante mecanismo pelo qual se acredita que o estresse oxidativo altera a fun&#231;&#227;o endotelial &#233; a inativa&#231;&#227;o do NO pelos &#226;nions super&#243;xidos e lipoprote&#237;nas de baixa densidade oxidadas (LDLs-ox). Esses RL desativam os receptores endoteliais para acetilcolina, serotonina, trombina, bradicinina e outros mediadores, diminuindo a estimula&#231;&#227;o da NOS nas c&#233;lulas endoteliais e, consequentemente, reduzindo a produ&#231;&#227;o de NO, prejudicando o relaxamento das c&#233;lulas musculares lisas e predispondo &#224; forma&#231;&#227;o da placa ateroscler&#243;tica<sup>6</sup>.</p>
    <p>Al&#233;m disso, a produ&#231;&#227;o de ERO pode reagir com a mol&#233;cula de NO e produzir o &#226;nion peroxinitrito (ONOO<sup>-</sup>) e di&#243;xido de nitrog&#234;nio, iniciando assim a peroxida&#231;&#227;o lip&#237;dica e potencializando a les&#227;o inflamat&#243;ria em c&#233;lulas vasculares, diminuindo a disponibilidade de NO para as c&#233;lulas e favorecendo os processos tromboemb&#243;licos<sup>2,35</sup>.</p>
    <p>A modifica&#231;&#227;o oxidativa de lipoprote&#237;nas circulat&#243;rias por RL, particularmente as lipoprote&#237;nas de baixa densidade (LDL), parece ser bastante importante para o desenvolvimento de les&#245;es ateroscler&#243;ticas, principalmente a oxida&#231;&#227;o de &#225;cidos graxos poliinsaturados na LDL, que parece ocorrer dentro das les&#245;es ateroscler&#243;ticas. Seguindo o processo de oxida&#231;&#227;o, LDL-ox estimula a migra&#231;&#227;o de mon&#243;citos circulantes para o espa&#231;o subendotelial e tamb&#233;m causa les&#227;o na c&#233;lula endotelial. A LDL-ox &#233; ent&#227;o capturada por macr&#243;fagos, mais rapidamente que o normal, para formar c&#233;lulas espumosas carregadas de colesterol. Esse processo histol&#243;gico prematuro leva ao desenvolvimento de placas ateroscler&#243;ticas<sup>6,7,35</sup>.</p>
    <p>Al&#233;m disso, a pr&#243;pria LDL-ox &#233; citot&#243;xica para as c&#233;lulas endoteliais. Ela tamb&#233;m promove a express&#227;o de citocinas, &#233; pr&#243;-inflamat&#243;ria, causa inibi&#231;&#227;o da eNOS, provoca vasoconstri&#231;&#227;o e ades&#227;o e aumenta a agrega&#231;&#227;o plaquet&#225;ria<sup>2,7,15</sup>.</p>
    <p>Fatores de risco para aterosclerose, como fumo, <italic>diabetes mellitus</italic>, hipertens&#227;o, hipercolesterolemia e outros, est&#227;o associados com o aumento da produ&#231;&#227;o de RL. A produ&#231;&#227;o excessiva de ERO promove a produ&#231;&#227;o direta de esp&#233;cies citot&#243;xicas e a inativa&#231;&#227;o de NO<sup>2,6</sup>. Essa inativa&#231;&#227;o leva &#224; perda dos efeitos protetores do NO, como regula&#231;&#227;o do t&#244;nus arterial, inibi&#231;&#227;o da inflama&#231;&#227;o local e da coagula&#231;&#227;o, como tamb&#233;m da prolifera&#231;&#227;o celular<sup>16-18</sup>.</p>
    <p>O efeito protetor do NO na aterosclerose ocorre por interm&#233;dio da inibi&#231;&#227;o da oxida&#231;&#227;o das mol&#233;culas de LDL colesterol e do impedimento da agrega&#231;&#227;o plaquet&#225;ria. O mecanismo pelo qual o NO impede a forma&#231;&#227;o da mol&#233;cula de LDL-ox se d&#225; por meio de sua a&#231;&#227;o antioxidante, impedindo a forma&#231;&#227;o de &#226;nions super&#243;xidos, que promovem a oxida&#231;&#227;o da mol&#233;cula de LDL colesterol<sup>36,37</sup>. A a&#231;&#227;o antiagregante do NO &#233; devida a sua liga&#231;&#227;o com a mol&#233;cula de guanilatociclase. Ela induz a forma&#231;&#227;o de guanilato monofosfato c&#237;clico (GMPc), que promove a redu&#231;&#227;o da concentra&#231;&#227;o de &#237;ons c&#225;lcio dentro da plaqueta, inibindo sua ativa&#231;&#227;o e agrega&#231;&#227;o<sup>38</sup>.</p>
    <p>A perda de NO prejudica esses mecanismos protetores, contribuindo para o desenvolvimento da aterosclerose. Acredita-se que o estresse oxidativo induz a uma disfun&#231;&#227;o endotelial na aterosclerose coron&#225;ria pelo aumento da degrada&#231;&#227;o e inibi&#231;&#227;o da s&#237;ntese de NO<sup>12</sup>.</p>
    <p>
      <bold>Exerc&#237;cio f&#237;sico e estresse oxidativo</bold>
    </p>
    <p>Taxas metab&#243;licas elevadas como resultado de exerc&#237;cio f&#237;sico podem aumentar dramaticamente o consumo de oxig&#234;nio (VO<sub>2m&#225;x</sub>) em at&#233; 20 vezes em rela&#231;&#227;o aos valores de repouso<sup>39</sup>. Esse aumento &#233; seguido por um concomitante aumento na produ&#231;&#227;o de ERO<sup>40</sup>. Entretanto, estudos t&#234;m demonstrado que o treinamento de <italic>endurance</italic> aumenta as defesas antioxidantes, assim como a capacidade oxidativa do m&#250;sculo<sup>40-42</sup>.</p>
    <p>O estresse oxidativo tem sido associado &#224; diminui&#231;&#227;o da performance, fadiga, dano muscular e excesso de treinamento. Por essa raz&#227;o, alguns pesquisadores<sup>8,39,41,43</sup> sugerem que reduzir o estresse oxidativo pode melhorar a toler&#226;ncia ao exerc&#237;cio, bem como a performance f&#237;sica.</p>
    <p>Embora os benef&#237;cios do aumento no VO<sub>2m&#225;x</sub> sejam bem estabelecidos, um paradoxo bioqu&#237;mico &#233; verificado. O aumento no consumo m&#225;ximo de O<sub>2</sub> &#233; essencial para a aptid&#227;o cardiovascular e performance, por&#233;m o aumento no consumo de O<sub>2</sub> durante o exerc&#237;cio f&#237;sico provoca um concomitante aumento na produ&#231;&#227;o de RL. Dependendo do tipo e da intensidade do exerc&#237;cio, t&#234;m sido propostos v&#225;rios mecanismos na gera&#231;&#227;o de ERO, dentre os quais destacam-se:</p>
    <p><italic>1 - Aumento na produ&#231;&#227;o de &#226;nion super&#243;xido (O<sub>2</sub>&#183;-) na cadeia respirat&#243;ria -</italic> Uma das principais fontes de RL durante o exerc&#237;cio f&#237;sico &#233; o vazamento de el&#233;trons que ocorre na cadeia de transporte de el&#233;trons. O aumento no consumo de oxig&#234;nio pelos tecidos durante o exerc&#237;cio intenso, teoricamente, levaria a um aumento proporcional de O<sub>2</sub>&#183;- e, por conseguinte, provocaria um aumento na peroxida&#231;&#227;o de lip&#237;dios mitocondriais, perda de grupos ti&#243;is em prote&#237;nas e inativa&#231;&#227;o de enzimas oxidativas<sup>33</sup>.</p>
    <p><italic>2 - Ativa&#231;&#227;o da xantina oxidase (XO) -</italic> A XO catalisa a degrada&#231;&#227;o do monofosfato de adenosina (AMP) durante o trabalho muscular isqu&#234;mico, levando ao aumento na produ&#231;&#227;o de O<sub>2</sub>&#183;-. Durante a isquemia, o AMP, formado do ATP (trifosfato de adenosina) pela rea&#231;&#227;o de adenilato quinase, &#233; degradado para hipoxantina. A XO &#233; convertida e, dessa forma, reduzida para xantina desidrogenase durante a isquemia por proteases intramusculares, as quais necessitam de Ca<sup>+2</sup>. A XO converte a hipoxantina para xantina e &#225;cido &#250;rico usando o oxig&#234;nio molecular como receptor de el&#233;trons, formando assim o O<sub>2</sub>&#183;-. Em condi&#231;&#245;es aer&#243;bicas, o oxig&#234;nio suficiente assegura que o ATP seja reposto via fosforila&#231;&#227;o oxidativa mitocondrial e que a hipoxantina e a xantina sejam, primeiramente, convertidas para &#225;cido &#250;rico por meio da xantina desidrogenase. Al&#233;m disso, o m&#250;sculo esquel&#233;tico tem baixa atividade da XO. Todavia, a XO pode ser um importante caminho quando o m&#250;sculo apresentar um d&#233;ficit de adenina dinucleot&#237;deo. Essa situa&#231;&#227;o, teoricamente, pode acontecer em situa&#231;&#227;o de isquemia, exerc&#237;cio isom&#233;trico, d&#233;ficit de O<sub>2</sub> e exerc&#237;cios com limita&#231;&#227;o vascular de fluxo sangu&#237;neo<sup>44</sup>.</p>
    <p><italic>3 - Ativa&#231;&#227;o de c&#233;lulas polimorfonucleares - </italic>As c&#233;lulas fagoc&#237;ticas, principalmente neutr&#243;filos e macr&#243;fagos, realizam um r&#225;pido consumo de oxig&#234;nio, processo conhecido como <italic>respiratory burst</italic>. Esse processo &#233; uma das fontes de forma&#231;&#227;o de super&#243;xido, per&#243;xido de hidrog&#234;nio, radical hidroxil, &#225;cido hipocloroso e peroxinitrito<sup>45</sup>. Al&#233;m de apresentarem a&#231;&#227;o antitumoral, alguns destes intermedi&#225;rios reativos derivados do oxig&#234;nio participam diretamente da defesa do hospedeiro contra bact&#233;rias, v&#237;rus, protozo&#225;rios e fungos<sup>33</sup>.</p>
    <p>O <italic>respiratory burst</italic> resulta da atividade da NADPH oxidase, uma enzima que catalisa a transfer&#234;ncia de el&#233;trons da NADPH para O<sub>2</sub> formando super&#243;xido. Na presen&#231;a da super&#243;xido dismutase (SOD), o super&#243;xido &#233; dismutado formando um importante agente microbicida, o per&#243;xido de hidrog&#234;nio<sup>45</sup>. O per&#243;xido de hidrog&#234;nio pode ser catalisado pela mieloperoxidase, presente principalmente em neutr&#243;filos, dando origem a uma toxina ainda mais potente na sua a&#231;&#227;o microbicida denominada &#225;cido hipocloroso (HOCl)<sup>46</sup>.</p>
    <p>Uma vez formado, o HOCl tende a oxidar amino&#225;cidos para s&#237;ntese de cloraminas. Estes &#250;ltimos derivados perdem Cle CO<sub>2</sub>, formando aminas que s&#227;o hidrolisadas para alde&#237;dos. No caso da treonina, o hidroxialde&#237;do resultante sofre desidrata&#231;&#227;o e origina a acrole&#237;na (subst&#226;ncia cancer&#237;gena que destr&#243;i fibras el&#225;sticas e irrita mucosas)<sup>46</sup>. O HOCl ainda reage com per&#243;xido de hidrog&#234;nio, formando oxig&#234;nio singlet (1O<sub>2</sub>). H&#225; ainda a possibilidade de formar radical hidroxila (&#183;OH) pela rea&#231;&#227;o de Haber-Weiss<sup>32</sup>.</p>
    <p>A neutrofilia induzida pelo exerc&#237;cio ocorre como resultado da migra&#231;&#227;o de neutr&#243;filos vindos dos tecidos endoteliais (mediada por catecolaminas) e da medula &#243;ssea (mediada pelo cortisol)<sup>47</sup>. Isso faz com que removam prote&#237;nas e c&#233;lulas danificadas e mortas. Embora seja uma rea&#231;&#227;o desej&#225;vel, quando n&#227;o bem regulada pode ser uma das causas de inflama&#231;&#245;es agudas. Isso ocorre devido a um grande aumento na produ&#231;&#227;o de mediadores pr&#243;-inflamat&#243;rios (interleucinas 1, 8, TNF-alfa) e prostaglandinas, levando &#224; indu&#231;&#227;o e &#224; intensifica&#231;&#227;o de processo inflamat&#243;rio adicional, aumentando a produ&#231;&#227;o de ERO (ativadores de fator transcri&#231;&#227;o NF-kB)<sup>48</sup>.Entretanto, mesmo que o exerc&#237;cio intenso induza a uma altera&#231;&#227;o significativa na produ&#231;&#227;o de ERO, estudos recentes mostram que o exerc&#237;cio f&#237;sico regular de <italic>endurance</italic> pode tornar mais eficiente o sistema de defesa antioxidante e melhorar a capacidade oxidativa dos sistemas org&#226;nicos, estabelecendo um equil&#237;brio entre os danos induzidos pelas ERO e os sistemas de reparos antioxidantes<sup>39-43</sup>.</p>
    <p>
      <bold>Exerc&#237;cio f&#237;sico e o endot&#233;lio</bold>
    </p>
    <p>In&#250;meros estudos indicam que exerc&#237;cios moderados a intensos est&#227;o associados com redu&#231;&#245;es importantes na incid&#234;ncia de eventos cardiovasculares, colocando o exerc&#237;cio f&#237;sico como uma importante modalidade terap&#234;utica na preven&#231;&#227;o e progn&#243;stico destas doen&#231;as<sup>49,50</sup>. Nos &#250;ltimos anos, foram descritos diversos benef&#237;cios do exerc&#237;cio regular para portadores de cardiopatia, al&#233;m da melhora na capacidade funcional<sup>51</sup>.</p>
    <p>A realiza&#231;&#227;o do exerc&#237;cio constitui um estresse fisiol&#243;gico para o organismo, em fun&#231;&#227;o do grande aumento da demanda energ&#233;tica em rela&#231;&#227;o ao repouso, o que provoca grande libera&#231;&#227;o de calor e intensa modifica&#231;&#227;o do ambiente qu&#237;mico muscular e sist&#234;mico. Consequentemente, a exposi&#231;&#227;o regular ao exerc&#237;cio ao longo do tempo (treinamento f&#237;sico) promove um conjunto de adapta&#231;&#245;es morfol&#243;gicas e funcionais que confere maior capacidade ao organismo para responder ao estresse porporcionado pelo exerc&#237;cio. &#201; importante destacar que os efeitos cr&#244;nicos do exerc&#237;cio dependem, fundamentalmente, de uma adapta&#231;&#227;o perif&#233;rica, que envolve tanto um melhor controle e uma distribui&#231;&#227;o do fluxo sangu&#237;neo como adapta&#231;&#245;es espec&#237;ficas da musculatura esquel&#233;tica<sup>52</sup>.</p>
    <p>Grande parte dos pacientes com DCV estabelecida refere diminui&#231;&#227;o da capacidade funcional, a qual se relaciona com redu&#231;&#227;o no VO<sub>2m&#225;x</sub> obtido durante realiza&#231;&#227;o de teste ergoespirom&#233;trico. Nesses pacientes, a capacidade de exerc&#237;cio &#233; determinada pela complexa intera&#231;&#227;o entre os sistemas cardiovascular, respirat&#243;rio, metab&#243;lico e muscular, somada &#224; modula&#231;&#227;o pelo sistema nervoso aut&#244;nomo (SNA). Dessa forma, qualquer desequil&#237;brio nessa intera&#231;&#227;o pode diminuir a capacidade funcional do indiv&#237;duo<sup>53</sup>.</p>
    <p>O conhecimento que envolve a rela&#231;&#227;o entre exerc&#237;cio f&#237;sico, preven&#231;&#227;o prim&#225;ria e secund&#225;ria da DAC j&#225; vem sendo amplamente discutido, e os resultados de in&#250;meros estudos mostram o impacto do exerc&#237;cio f&#237;sico no tratamento dessa doen&#231;a<sup>54,55</sup>. Entre muitos estudos, pode-se destacar duas metaan&#225;lises que confirmaram uma importante redu&#231;&#227;o de 20% a 25% na mortalidade por DCV em pacientes submetidos &#224; reabilita&#231;&#227;o card&#237;aca<sup>56,57</sup>.</p>
    <p>Estudos em seres humanos e em animais de laborat&#243;rio mostram que o <italic>shear stress </italic>(for&#231;a que o sangue exerce sobre a parede das art&#233;rias), induzido pelo exerc&#237;cio f&#237;sico, &#233; um poderoso est&#237;mulo para a libera&#231;&#227;o de fatores vasorelaxantes produzidos pelo endot&#233;lio vascular, como o NO. Ficou demonstrado que o treinamento f&#237;sico moderado aumenta o relaxamento da musculatura lisa vascular e n&#227;o vascular, e que esse maior relaxamento se deve &#224; maior produ&#231;&#227;o de NO pelas c&#233;lulas endoteliais, em resposta ao exerc&#237;cio f&#237;sico<sup>12,58-60</sup>. Al&#233;m disso, observou-se que o <italic>shear stress</italic> induzido pelo exerc&#237;cio f&#237;sico aumenta a express&#227;o da NOS endotelial e neuronal<sup>60-63</sup>.</p>
    <p>Assim, durante o exerc&#237;cio f&#237;sico, ocorre aumento do d&#233;bito card&#237;aco e redistribui&#231;&#227;o do fluxo sangu&#237;neo para musculatura esquel&#233;tica e circula&#231;&#227;o coronariana. Esse mecanismo &#233; mediado pela eNOS, cuja express&#227;o gen&#233;tica pode ser potencializada com exerc&#237;cios aer&#243;bios regulares<sup>62,64</sup>.</p>
    <p>Segundo Taddei e cols.<sup>65</sup>, o treinamento f&#237;sico pode prevenir a disfun&#231;&#227;o endotelial por meio do reparo da disponibilidade de NO consequente &#224; preven&#231;&#227;o do estresse oxidativo. Essas evid&#234;ncias sugerem que o exerc&#237;cio f&#237;sico pode prevenir ou atenuar o decl&#237;nio na vasodilata&#231;&#227;o endot&#233;lio-dependente.</p>
    <p>Dessa forma, os efeitos ben&#233;ficos da pr&#225;tica de exerc&#237;cio regular sobre as DCV s&#227;o associados, principalmente, &#224; maior produ&#231;&#227;o de agentes vasodilatadores derivados do endot&#233;lio, com consequente redu&#231;&#227;o da resist&#234;ncia vascular perif&#233;rica, diminui&#231;&#227;o dos n&#237;veis de LDL colesterol e inibi&#231;&#227;o da agrega&#231;&#227;o plaquet&#225;ria<sup>22,60</sup>.</p>
    <p>Resultados de estudos recentes t&#234;m demonstrado que o treinamento f&#237;sico provoca melhora expressiva na perfus&#227;o mioc&#225;rdica<sup>1</sup>. Entre os componentes envolvidos, pode-se citar:</p>
    <p><italic>1 - A fun&#231;&#227;o endotelial - </italic>O aumento frequente da press&#227;o transmural no vaso sangu&#237;neo, decorrente do exerc&#237;cio repetido, leva &#224; melhora no funcionamento endotelial, facilitando a perfus&#227;o mioc&#225;rdica. Esse mecanismo de vasodilata&#231;&#227;o, mediado pela a&#231;&#227;o endotelial, tem sido apontado como uma das principais adapta&#231;&#245;es vasculares provocadas pelo treinamento f&#237;sico<sup>49,59,62,66</sup>. H&#225; ainda estudos com animais que demonstram a melhora no vaso-relaxamento do endot&#233;lio, decorrente do exerc&#237;cio f&#237;sico<sup>60</sup>.</p>
    <p><italic>2 - Velocidade de s&#237;ntese e de degrada&#231;&#227;o de NO - </italic>Na tentativa de compensar a forma&#231;&#227;o de peroxinitrito, as c&#233;lulas musculares lisas presentes no vaso produzem uma enzima antioxidativa, a SOD, que bloqueia a a&#231;&#227;o dos RL, diminuindo dessa forma a degrada&#231;&#227;o do NO. Estudos em animais e em humanos t&#234;m demonstrado que o treinamento f&#237;sico aumenta a express&#227;o dessa enzima antioxidativa, assim como a produ&#231;&#227;o e express&#227;o da NOS<sup>12,67</sup>.</p>
    <p><italic>3 - A microcircula&#231;&#227;o -</italic> Estudos t&#234;m lan&#231;ado a hip&#243;tese de que o treinamento f&#237;sico tamb&#233;m estimularia a produ&#231;&#227;o de NO na microcircula&#231;&#227;o, com consequente a&#231;&#227;o vasodilatadora. Evid&#234;ncias mostram que a capacidade vasodilatadora dos vasos de resist&#234;ncia (microcircula&#231;&#227;o) se intensifica ap&#243;s quatro semanas de treinamento, sendo este fato de fundamental import&#226;ncia para a perfus&#227;o mioc&#225;rdica<sup>59,62,63</sup>. Os resultados do estudo realizado por Yoshinaga e cols.<sup>68</sup> - que apresentam diferen&#231;as entre a melhora das reservas de fluxo coron&#225;ria em segmentos anormais e normais ap&#243;s treinamento f&#237;sico - reflete esta a&#231;&#227;o vasodilatadora da microcircula&#231;&#227;o. Estes autores acreditam que as respostas do exerc&#237;cio na microcircula&#231;&#227;o s&#227;o multifatoriais e complexas, envolvendo tamb&#233;m a fun&#231;&#227;o muscular lisa, a fun&#231;&#227;o endotelial, a densidade capilar, a regress&#227;o da doen&#231;a e a circula&#231;&#227;o colateral.</p>
    <p><italic>4 - Regress&#227;o de les&#245;es ateroscler&#243;tica - </italic>Estudos demonstraram que o exerc&#237;cio f&#237;sico, associado ao controle dos n&#237;veis de colesterol (dieta hipogordurosa), atenua a progress&#227;o das les&#245;es coronarianas em longo prazo (quatro a seis anos de exerc&#237;cio), podendo levar &#224; regress&#227;o da placa ateroscler&#243;tica mioc&#225;rdio<sup>69-71</sup>. Este fen&#244;meno, considerado por muitos controverso, apresenta indiscutivelmente a possibilidade de melhora na perfus&#227;o do mioc&#225;rdio<sup>69-71</sup>. Por outro lado, o benef&#237;cio do exerc&#237;cio f&#237;sico realizado em curto prazo &#233; incerto<sup>72</sup>. </p>
    <p><italic>5 - Neoforma&#231;&#227;o de vasos colaterais -</italic> Pesquisas em animais demonstraram que o estreitamento do calibre das art&#233;rias coron&#225;rias induz o aparecimento de circula&#231;&#227;o colateral, e que este aumento na circula&#231;&#227;o &#233; potencializado quando estes animais s&#227;o submetidos a um programa de exerc&#237;cio<sup>70,71</sup>. No entanto, estudos de perfus&#227;o mioc&#225;rdica com a cintilografia t&#234;m apresentado resultados conflitantes em pacientes coronarianos submetidos a um programa regular de exerc&#237;cio. Diante dos fatos, percebe-se que o efeito do treinamento na forma&#231;&#227;o de vasos colaterais &#233; ainda incerto<sup>63,68,69,73</sup>. De forma geral, estudos angiogr&#225;ficos em humanos t&#234;m encontrado dificuldades em provar o aumento da circula&#231;&#227;o colateral em pacientes coronarianos submetidos ao exerc&#237;cio f&#237;sico, fato que pode ser justificado pela incapacidade deste exame em identificar art&#233;rias colaterais de pequeno tamanho (&lt; 100 &#181;m).</p>
    <p><italic>6 - Redu&#231;&#227;o da viscosidade sangu&#237;nea - </italic>O exerc&#237;cio f&#237;sico realizado de forma regular causa aumento no volume plasm&#225;tico, al&#233;m de redu&#231;&#227;o de algumas prote&#237;nas plasm&#225;ticas, como fibrinog&#234;nio e globulinas, processo definido como hemodilui&#231;&#227;o cr&#244;nica<sup>74,75</sup>. Apesar desse aumento do volume plasm&#225;tico, n&#227;o h&#225; consenso em rela&#231;&#227;o &#224; queda do hemat&#243;crito com o exerc&#237;cio cr&#244;nico<sup>75,76</sup>. Paralelamente, ocorre redu&#231;&#227;o da viscosidade plasm&#225;tica, que pode alcan&#231;ar at&#233; 8% em atletas de <italic>endurance</italic><sup>75,77</sup>. Contudo, esta queda da viscosidade com o exerc&#237;cio f&#237;sico n&#227;o foi demonstrada em pacientes coronarianos, permanecendo a d&#250;vida do real efeito do exerc&#237;cio f&#237;sico sobre a viscosidade sangu&#237;nea nestes pacientes<sup>73,78</sup>.</p>
    <p><italic>7 - Aumento do tempo de perfus&#227;o diast&#243;lica - </italic>Em estudo realizado com pacientes coronarianos submetidos a um programa regular de exerc&#237;cio f&#237;sico, houve diminui&#231;&#227;o da frequ&#234;ncia card&#237;aca basal, com maior tempo de perfus&#227;o diast&#243;lica em repouso. Da mesma forma, este aumento do tempo de perfus&#227;o diast&#243;lica se manifestou no pico de exerc&#237;cio, atenuando as manifesta&#231;&#245;es isqu&#234;micas ao eletrocardiograma (ECG)<sup>63,79</sup>.</p>
    <p>Portanto, sabe-se claramente que o exerc&#237;cio f&#237;sico melhora a capacidade f&#237;sica, a toler&#226;ncia ao exerc&#237;cio e os sintomas em pacientes com DAC, reduzindo as taxas de mortalidade. No entanto, os mecanismos bioqu&#237;micos pelos quais estes benef&#237;cios se estabelecem ainda n&#227;o est&#227;o completamente compreendidos. Apesar de a melhora da fun&#231;&#227;o endotelial ser o fen&#244;meno mais precoce (de quatro a seis semanas) do aumento do fluxo coronariano em indiv&#237;duos treinados, &#233; precipitado assegurar que este seja o &#250;nico mecanismo envolvido na melhora da perfus&#227;o mioc&#225;rdica<sup>1,68</sup>.</p>
    <p>
      <bold>Considera&#231;&#245;es finais</bold>
    </p>
    <p>Diante do exposto, fica claro o papel que o estresse oxidativo exerce na g&#234;nese e progress&#227;o das DCV como a DAC. Dentre as in&#250;meras interven&#231;&#245;es terap&#234;uticas empregadas para estas doen&#231;as, o exerc&#237;cio f&#237;sico desponta como uma importante ferramenta na manuten&#231;&#227;o e/ou recupera&#231;&#227;o da fun&#231;&#227;o endotelial, sendo seus benef&#237;cios bastante documentados na literatura atual.</p>
    <p>No entanto, mais estudos se mostram necess&#225;rios, a fim de que se possa esclarecer todos os mecanismos envolvidos nesta a&#231;&#227;o terap&#234;utica. Tamb&#233;m &#233; preciso que se permita uma an&#225;lise da intensidade de treinamento mais adequada a estes pacientes, servindo de orienta&#231;&#227;o para profissionais que trabalham com prescri&#231;&#227;o e orienta&#231;&#227;o do exerc&#237;cio f&#237;sico para indiv&#237;duos com DCV, buscando a redu&#231;&#227;o da preval&#234;ncia destas doen&#231;as na popula&#231;&#227;o mundial.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo foi parcialmente financiado por Mutrimental SA e CNPq.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Mar&#237;lia Costa de Ara&#250;jo pelo programa de p&#243;s-gradua&#231;&#227;o em Ci&#234;ncias da Sa&#250;de da UNESCO. </p>
    <p>
      <fn id="linkcorresp" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Ricardo Aurino de Pinho </p>
        <p> Laborat&#243;rio de Fisiologia e Bioqu&#237;mica do Exerc&#237;cio/UNESC </p>
        <p> Av. Universit&#225;ria, 1105 - Bairro Universit&#225;rio </p>
        <p> 88806-000 - Crici&#250;ma - SC - Brasil </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="pinho@unesc.net">pinho@unesc.net</email>
        </p>
      </fn>
    </p>
    <p> Artigo recebido em 15/10/08; revisado recebido em 19/01/09; aceito em 03/03/09.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Franco FGM, Matos LDNJ. Exerc&#237;cio f&#237;sico e perfus&#227;o mioc&#225;rdica. In: Negr&#227;o CE, Barreto AC (eds). Cardiologia do exerc&#237;cio: do atleta ao cardiopata. S&#227;o Paulo: Manole; 2005. p. 179-259.</mixed-citation>
        <element-citation publication-type="book">
          <source>Cardiologia do exerc&#237;cio: do atleta ao cardiopata</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>179</fpage>
          <lpage>259</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Franco</surname>
              <given-names>FGM</given-names>
            </name>
            <name>
              <surname>Matos</surname>
              <given-names>LDNJ</given-names>
            </name>
            <name>
              <surname>Negr&#227;o</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Barreto</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol. 2004; 84 (4): 1381-478.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Role of oxidative modifications in atherosclerosis</article-title>
          <source>Physiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1381</fpage>
          <lpage>478</lpage>
          <issue>4</issue>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stocker</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Keaney</surname>
              <given-names>JF Jr</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Instituto Brasileiro de Geografia e Estat&#237;stica (IBGE). [homepage na Internet]. S&#237;ntese de indicadores sociais 2002 [Citado 2006 abril 10]. S&#237;ntese de Indicadores Sociais confirma as desigualdades da sociedade brasileira. Dispon&#237;vel em: <ext-link ext-link-type="uri" xlink:href="http://www.ibge.gov.br">http://www.ibge.gov.br</ext-link>.</mixed-citation>
        <element-citation publication-type="book">
          <source>S&#237;ntese de indicadores sociais 2002</source>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Hermann J, Lerman A. The endothelium: dysfunction and beyond. J Nucl Cardiol. 2001; 8: 197-206.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The endothelium: dysfunction and beyond</article-title>
          <source>J Nucl Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>197</fpage>
          <lpage>206</lpage>
          <volume>8</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hermann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lerman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Tsao PS, Niebauer J, Buitrago R, Lin PS, Wang BY, Cooke JP, et al. Interaction of diabetes and hypertension on determinants of endothelial adhesiveness. Arterioscler Thromb Vasc Biol. 1998; 18: 947-53.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Interaction of diabetes and hypertension on determinants of endothelial adhesiveness</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>947</fpage>
          <lpage>53</lpage>
          <volume>18</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Tsao</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Niebauer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Buitrago</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>BY</given-names>
            </name>
            <name>
              <surname>Cooke</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Antoniades C, Tousoulis D, Tentolouris C, Toutouzas P, Stefanadis C. Oxidative stress, antioxidant vitamins, and atherosclerosis. Herz. 2003; 28: 628-38.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Oxidative stress, antioxidant vitamins, and atherosclerosis</article-title>
          <source>Herz</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>628</fpage>
          <lpage>38</lpage>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Antoniades</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tousoulis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tentolouris</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Toutouzas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Stefanadis</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology. 2006; 13: 129-42.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Oxidative stress and atherosclerosis</article-title>
          <source>Pathophysiology</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>129</fpage>
          <lpage>42</lpage>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Singh</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Jialal</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Polidori MC, Mecocci P, Cherubini A, Senin U. Physical activity and oxidative stress during aging. Int J Sports Med. 2000; 21: 154-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Physical activity and oxidative stress during aging</article-title>
          <source>Int J Sports Med</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>154</fpage>
          <lpage>7</lpage>
          <volume>21</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Polidori</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Mecocci</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cherubini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Senin</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. MacNee W, Rahman I. Is oxidative stress central the pathogenisis of chronic obstructive pulmonary disease? Trends Mol Med. 2001; 7: 55-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Is oxidative stress central the pathogenisis of chronic obstructive pulmonary disease?</article-title>
          <source>Trends Mol Med</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>55</fpage>
          <lpage>62</lpage>
          <volume>7</volume>
          <person-group person-group-type="author">
            <name>
              <surname>MacNee</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Rahman</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Sureda A, Ferrer MD, Tauler P, Romaguera D, Drobnic F, Pujol P, et al. Effects of exercise intensity on lymphocyte H<sub>2</sub>O<sub>2</sub> production and antioxidant defences in soccer players. Br J Sports Med. 2009; 43 (3): 186-90.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of exercise intensity on lymphocyte H2O2 production and antioxidant defences in soccer players</article-title>
          <source>Br J Sports Med</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>186</fpage>
          <lpage>90</lpage>
          <issue>3</issue>
          <volume>43</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sureda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferrer</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Tauler</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Romaguera</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Drobnic</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pujol</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Reid MB. Free radicals and muscle fatigue: Of ROS, canaries, and the IOC. Free Radic Biol Med. 2008; 44 (2): 169-79.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Free radicals and muscle fatigue: Of ROS, canaries, and the IOC</article-title>
          <source>Free Radic Biol Med</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>169</fpage>
          <lpage>79</lpage>
          <issue>2</issue>
          <volume>44</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Reid</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Goto C, Higashi Y, Kimura M, Noma K, Hara K, Nakagawa K, et al. Effect of different intensities of exercise on endothelium-dependent vasodilatation in humans: role of endothelium-dependent nitric oxide and oxidative stress. Circulation. 2003; 108: 530-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of different intensities of exercise on endothelium-dependent vasodilatation in humans: role of endothelium-dependent nitric oxide and oxidative stress</article-title>
          <source>Circulation</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>530</fpage>
          <lpage>5</lpage>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Goto</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Higashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Noma</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hara</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Farsidfar F, Kasikcioglu E, Oflaz H, Kasikcioglu D, Meric M, Umman S. Effects of different intensities of acute exercise on flow-mediated dilatation in patients with coronary heart disease. Int J Cardiol. 2008; 124 (3): 372-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of different intensities of acute exercise on flow-mediated dilatation in patients with coronary heart disease</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>372</fpage>
          <lpage>4</lpage>
          <issue>3</issue>
          <volume>124</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Farsidfar</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kasikcioglu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Oflaz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kasikcioglu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Meric</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Umman</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Wisl&#248;ff U, St&#248;ylen A, Loennechen JP, Bruvold M, Rognmo &#216;, Haram PM, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation. 2007; 115: 3086-94.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study</article-title>
          <source>Circulation</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>3086</fpage>
          <lpage>94</lpage>
          <volume>115</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Wisl&#248;ff</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>St&#248;ylen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Loennechen</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Bruvold</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rognmo</surname>
              <given-names>&#216;</given-names>
            </name>
            <name>
              <surname>Haram</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. S&#225;nchez-Quesada JL, Ortega H, Pay&#233;s-Romero A, Serrat-Serrat J, Gonz&#225;lez-Sastre F; Lasunci&#243;n MA, et al. LDL from aerobically-trained subjects shows higher resistance to oxidative modification than LDL from sedentary subjects. Atherosclerosis. 1997; 132: 207-13.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>LDL from aerobically-trained subjects shows higher resistance to oxidative modification than LDL from sedentary subjects</article-title>
          <source>Atherosclerosis</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>207</fpage>
          <lpage>13</lpage>
          <volume>132</volume>
          <person-group person-group-type="author">
            <name>
              <surname>S&#225;nchez-Quesada</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Ortega</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pay&#233;s-Romero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Serrat-Serrat</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gonz&#225;lez-Sastre</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lasunci&#243;n</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Laughlin MH, Oltman CL, Bowles DK. Exercise training-induced adaptations in the coronary circulation. Med Sci Sports Exerc. 1998; 30: 352-60.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise training-induced adaptations in the coronary circulation</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>352</fpage>
          <lpage>60</lpage>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Laughlin</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Oltman</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Bowles</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Brown MD. Exercise and coronary vascular remodelling in the healthy heart. Exp Physiol. 2003; 88 (5): 645-58.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise and coronary vascular remodelling in the healthy heart</article-title>
          <source>Exp Physiol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>645</fpage>
          <lpage>58</lpage>
          <issue>5</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Linke A, Erbs S, Hambrecht R. Exercise and the coronary circulation-alterations and adaptations in coronary artery disease. Prog Cardiovasc Dis. 2006; 48 (4): 270-84.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise and the coronary circulation-alterations and adaptations in coronary artery disease</article-title>
          <source>Prog Cardiovasc Dis</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>270</fpage>
          <lpage>84</lpage>
          <issue>4</issue>
          <volume>48</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Linke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Erbs</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hambrecht</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Johnstone MH, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager BK. Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation. 1999; 88: 2510-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus</article-title>
          <source>Circulation</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>2510</fpage>
          <lpage>6</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Johnstone</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Creager</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Scales</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Cusco</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Creager</surname>
              <given-names>BK</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20. Rush JW, Ford RJ. Nitric oxide, oxidative stress and vascular endothelium in health and hypertension. Clin Hemorheol Microcirc. 2007; 37 (1-2): 185-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nitric oxide, oxidative stress and vascular endothelium in health and hypertension</article-title>
          <source>Clin Hemorheol Microcirc</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>185</fpage>
          <lpage>92</lpage>
          <issue>1-2</issue>
          <volume>37</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rush</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Ford</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Desjardins F, Balligand JL. Nitric oxide-dependent endothelial function and cardiovascular disease. Acta Clin Belg. 2006; 61 (6): 326-34.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nitric oxide-dependent endothelial function and cardiovascular disease</article-title>
          <source>Acta Clin Belg</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>326</fpage>
          <lpage>34</lpage>
          <issue>6</issue>
          <volume>61</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Desjardins</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Balligand</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Kingwell BA. Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. Exp Biol. 2000; 14: 1685-96.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease</article-title>
          <source>Exp Biol</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1685</fpage>
          <lpage>96</lpage>
          <volume>14</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kingwell</surname>
              <given-names>BA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Ross R, Glomaser JA. Atherosclerosis and arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science. 1973; 180: 1332-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Atherosclerosis and arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis</article-title>
          <source>Science</source>
          <date>
            <year>1973</year>
          </date>
          <fpage>1332</fpage>
          <lpage>9</lpage>
          <volume>180</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Glomaser</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol. 1995; 15 (9): 1512-31.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>1512</fpage>
          <lpage>31</lpage>
          <issue>9</issue>
          <volume>15</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stary</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Chandler</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Dinsmore</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Fuster</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Glagov</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Insull</surname>
              <given-names>W Jr</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Reddy KG, Nair RN, Sheeran HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 1994; 23: 833-43.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>833</fpage>
          <lpage>43</lpage>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Reddy</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Sheeran</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Hodgson</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary segments. N Engl J Med. 1986; 315: 1046-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary segments</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>1986</year>
          </date>
          <fpage>1046</fpage>
          <lpage>51</lpage>
          <volume>315</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ludmer</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Selwyn</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Shook</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Wayne</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Mudge</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Alexander</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. El-Tamimi H, Mansour M, Wargovich TJ, Hill JA, Kerensky RA, Conti CR, et al. Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease. Endothelial function revisited. Circulation. 1994; 89 (1): 45-51.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease: Endothelial function revisited</article-title>
          <source>Circulation</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>45</fpage>
          <lpage>51</lpage>
          <issue>1</issue>
          <volume>89</volume>
          <person-group person-group-type="author">
            <name>
              <surname>El-Tamimi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mansour</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wargovich</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Kerensky</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Conti</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Davies MJ. Going from immutable to mutable atherosclerotic plaques. Am J Cardiol. 2001; 88: 2-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Going from immutable to mutable atherosclerotic plaques</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>2</fpage>
          <lpage>9</lpage>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Rozanski A, Qureshi E, Bauman M, Reed G, Pillar G, Diamond GA. Peripheral arterial responses to treadmill exercise among healthy subjects and atherosclerotic patients. Circulation. 2001; 103: 2084-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Peripheral arterial responses to treadmill exercise among healthy subjects and atherosclerotic patients</article-title>
          <source>Circulation</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>2084</fpage>
          <lpage>9</lpage>
          <volume>103</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rozanski</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Qureshi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bauman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pillar</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Diamond</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. De Meyer G, Herman AG. Vascular endothelial dysfunction. Prog Cardiovasc Dis. 1997; 39: 325-42.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Vascular endothelial dysfunction</article-title>
          <source>Prog Cardiovasc Dis</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>325</fpage>
          <lpage>42</lpage>
          <volume>39</volume>
          <person-group person-group-type="author">
            <name>
              <surname>De Meyer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Herman</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Greig D, Castro P, Gabrielli L, Miranda R, Verdejo H, Alca&#237;no H, et al. Inflammation and endothelial dysfunction in patients with chronic heart failure. Rev Med Chil. 2008; 136 (6): 687-93.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Inflammation and endothelial dysfunction in patients with chronic heart failure</article-title>
          <source>Rev Med Chil</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>687</fpage>
          <lpage>93</lpage>
          <issue>6</issue>
          <volume>136</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Greig</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gabrielli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Miranda</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Verdejo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Alca&#237;no</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. Oxford: University Press; 2007.</mixed-citation>
        <element-citation publication-type="book">
          <source>Free radicals in biology and medicine</source>
          <date>
            <year>2007</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Halliwell</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gutteridge</surname>
              <given-names>JMC</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Matsuo M, Kaneko T. The chemistry os reactive oxygen species and related free radicals. In: Radak Z. (ed.). Free radicals in exercise and aging. Champaign: Human Kinetics; 2001. p. 1-33.</mixed-citation>
        <element-citation publication-type="book">
          <source>Free radicals in exercise and aging</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1</fpage>
          <lpage>33</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Matsuo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kaneko</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Radak</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Lorgeril M, Salen P, Accominotti M. Dietary and blood antioxidants in patients with chronic heart failure: insights into the potential importance of selenium in heart failure. Eur J Heart Fail. 2001; 3 (6): 661-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Dietary and blood antioxidants in patients with chronic heart failure: insights into the potential importance of selenium in heart failure</article-title>
          <source>Eur J Heart Fail</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>661</fpage>
          <lpage>9</lpage>
          <issue>6</issue>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lorgeril</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Salen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Accominotti</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Yung LM, Leung FP, Yao X, Chen ZY, Huang Y. Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets. 2006; 6 (1): 1-19.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Reactive oxygen species in vascular wall</article-title>
          <source>Cardiovasc Hematol Disord Drug Targets</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1</fpage>
          <lpage>19</lpage>
          <issue>1</issue>
          <volume>6</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yung</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>FP</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>ZY</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B36">
        <mixed-citation>36. Mombouli JV, Vanhoutte PM. Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol. 1999; 31: 61-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Endothelial dysfunction: from physiology to therapy</article-title>
          <source>J Mol Cell Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>61</fpage>
          <lpage>74</lpage>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mombouli</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Vanhoutte</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B37">
        <mixed-citation>37. Thomas SR, Chen K, Keaney JF Jr. Oxidative stress and endothelial nitric oxide bioactivity. Antioxid Redox Signal. 2003; 5 (2): 181-94.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Oxidative stress and endothelial nitric oxide bioactivity</article-title>
          <source>Antioxid Redox Signal</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>181</fpage>
          <lpage>94</lpage>
          <issue>2</issue>
          <volume>5</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Thomas</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Keaney</surname>
              <given-names>JF Jr</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B38">
        <mixed-citation>38. Hobbs AJ, Moncada S. Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator. Vascul Pharmacol. 2003; 40: 149-54.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator</article-title>
          <source>Vascul Pharmacol</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>149</fpage>
          <lpage>54</lpage>
          <volume>40</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hobbs</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Moncada</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B39">
        <mixed-citation>39. Carmeli E, Laviam G, Reznick AZ. The role of antioxidant nutrition in exercise and aging. In: Rad&#225;k Z, (ed.). Free radicals in exercise and aging. Champaign: Human Kinetics; 2000. p. 73-115.</mixed-citation>
        <element-citation publication-type="book">
          <source>Free radicals in exercise and aging</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>73</fpage>
          <lpage>115</lpage>
          <person-group person-group-type="author">
            <name>
              <surname>Carmeli</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Laviam</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Reznick</surname>
              <given-names>AZ</given-names>
            </name>
            <name>
              <surname>Rad&#225;k</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B40">
        <mixed-citation>40. Alessio HM, Goldfarb AH. Lipid peroxidation and scavenger enzymes during exercise: adaptative response to training. J Appl Physiol. 1988; 64: 1333-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Lipid peroxidation and scavenger enzymes during exercise: adaptative response to training</article-title>
          <source>J Appl Physiol</source>
          <date>
            <year>1988</year>
          </date>
          <fpage>1333</fpage>
          <lpage>6</lpage>
          <volume>64</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Alessio</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Goldfarb</surname>
              <given-names>AH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B41">
        <mixed-citation>41. Rad&#225;k Z, Kaneko T, Tahara S, Nakamoto H, Ohno H, Sasv&#225;ri M, et al. The effect of exercise training on oxidative damage of lipids, proteins, and dna in rat skeletal muscle: evidence for beneficial outcome. Free Radic Biol Med. 1999; 27 (1-2): 69-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effect of exercise training on oxidative damage of lipids, proteins, and dna in rat skeletal muscle: evidence for beneficial outcome</article-title>
          <source>Free Radic Biol Med</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>69</fpage>
          <lpage>74</lpage>
          <issue>1-2</issue>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rad&#225;k</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Kaneko</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tahara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nakamoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sasv&#225;ri</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B42">
        <mixed-citation>42. Terblanche SE. The effects of exhaustive exercise on the activity levels of catalase in various tissues of male and female rats. Cell Biol Int. 2000; 23: 749-53.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The effects of exhaustive exercise on the activity levels of catalase in various tissues of male and female rats</article-title>
          <source>Cell Biol Int</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>749</fpage>
          <lpage>53</lpage>
          <volume>23</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Terblanche</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B43">
        <mixed-citation>43. Powers SK, Ji LL, Leeuwenburg C. Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review. Med Sci Sports Exerc. 1999; 31: 987-97.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>987</fpage>
          <lpage>97</lpage>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Powers</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Leeuwenburg</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B44">
        <mixed-citation>44. Ji LL. Aging and acute exercise enhance free radical generation in rat skeletal muscle. J Appl Physiol. 1999; 87: 465-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Aging and acute exercise enhance free radical generation in rat skeletal muscle</article-title>
          <source>J Appl Physiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>465</fpage>
          <lpage>70</lpage>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ji</surname>
              <given-names>LL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B45">
        <mixed-citation>45. Iles KE, Forman HJ. Macrophage signaling and respiratory burst. Immunol Res. 2002; 26: 95-106.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Macrophage signaling and respiratory burst</article-title>
          <source>Immunol Res</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>95</fpage>
          <lpage>106</lpage>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Iles</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Forman</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B46">
        <mixed-citation>46. K&#246;nig D, Berg A. Exercise and oxidative stress: is there a need for additional antioxidants. Sportmedizin. 2002; 3: 6-15.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise and oxidative stress: is there a need for additional antioxidants</article-title>
          <source>Sportmedizin</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>6</fpage>
          <lpage>15</lpage>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>K&#246;nig</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Berg</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B47">
        <mixed-citation>47. Trevor CC, Sandy SH. Effects of a 7-day eccentric training period on muscle damage and inflammation. Med Sci Sports Exerc. 2001; 33: 1732-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of a 7-day eccentric training period on muscle damage and inflammation</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1732</fpage>
          <lpage>8</lpage>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Trevor</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Sandy</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B48">
        <mixed-citation>48. Mastaloudis, Morrow JD, Hopkins DW, Devaraj S, Traber MG. Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radic Biol Med. 2004; 36: 1329-41.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners</article-title>
          <source>Free Radic Biol Med</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>1329</fpage>
          <lpage>41</lpage>
          <volume>36</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Mastaloudis</surname>
            </name>
            <name>
              <surname>Morrow</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Hopkins</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Devaraj</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Traber</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B49">
        <mixed-citation>49. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000; 342: 454-60.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of exercise on coronary endothelial function in patients with coronary artery disease</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>454</fpage>
          <lpage>60</lpage>
          <volume>342</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hambrecht</surname>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gielen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Linke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hofer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Erbs</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B50">
        <mixed-citation>50. Manson JE, Greenland P, LaCroix AZ, Stefanick ML, Mouton CP, Oberman A, et al. Walking compared with vigorous exercise for prevention of cardiovascular events in women. N Engl J Med. 2002; 347: 716-25.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Walking compared with vigorous exercise for prevention of cardiovascular events in women</article-title>
          <source>N Engl J Med</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>716</fpage>
          <lpage>25</lpage>
          <volume>347</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Manson</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Greenland</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>LaCroix</surname>
              <given-names>AZ</given-names>
            </name>
            <name>
              <surname>Stefanick</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Mouton</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Oberman</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B51">
        <mixed-citation>51. Ara&#250;jo CGS, Carvalho T, Castro CLB, Costa RV, Moraes RS, Oliveira JAF, et al. Normatiza&#231;&#227;o dos equipamentos e t&#233;cnicas da reabilita&#231;&#227;o cardiovascular supervisionada. Arq Bras Cardiol. 2004; 83: 448-52.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Normatiza&#231;&#227;o dos equipamentos e t&#233;cnicas da reabilita&#231;&#227;o cardiovascular supervisionada</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>448</fpage>
          <lpage>52</lpage>
          <volume>83</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ara&#250;jo</surname>
              <given-names>CGS</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>CLB</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Moraes</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>JAF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B52">
        <mixed-citation>52. Sociedade Brasileira de Cardiologia. Diretriz de reabilita&#231;&#227;o card&#237;aca. Arq Bras Cardiol. 2005; 84 (5): 431-40.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diretriz de reabilita&#231;&#227;o card&#237;aca</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>431</fpage>
          <lpage>40</lpage>
          <issue>5</issue>
          <volume>84</volume>
        </element-citation>
      </ref>
      <ref id="B53">
        <mixed-citation>53. Stone JA, Cyr C, Friesen M, Kennedy-Symonds H, Stene R, Smilovitch M. Canadian guidelines for cardiac rehabilitation and atherosclerotic heart disease prevention: a summary. Can J Cardiol. 2001; 17: 3B-30B.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Canadian guidelines for cardiac rehabilitation and atherosclerotic heart disease prevention: a summary</article-title>
          <source>Can J Cardiol</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>3B</fpage>
          <lpage>30B</lpage>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Stone</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Cyr</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Friesen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kennedy-Symonds</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Stene</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Smilovitch</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B54">
        <mixed-citation>54. Fattirolli F, Cartei A, Burgisser C, Mottino G, Del Lungo F, Oldridge N, et al. Aims, design and enrollment rate of the Cardiac Rehabilitation in Advanced Age (CRAGE) randomized, controlled trial. Aging (Milano). 1998; 10 (5): 368-76.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Aims, design and enrollment rate of the Cardiac Rehabilitation in Advanced Age (CRAGE) randomized, controlled trial</article-title>
          <source>Aging (Milano)</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>368</fpage>
          <lpage>76</lpage>
          <issue>5</issue>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fattirolli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cartei</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Burgisser</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mottino</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Del Lungo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Oldridge</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B55">
        <mixed-citation>55. Marchionni N, Fattirolli F, Fumagalli S, Oldridge N, Del Lungo F, Morosi L, et al. Improved exercise tolerance and quality of life with cardiac rehabilitation of older patients after myocardial infarction: results of a randomized, controlled trial. Circulation. 2003; 107 (17): 2201-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Improved exercise tolerance and quality of life with cardiac rehabilitation of older patients after myocardial infarction: results of a randomized, controlled trial</article-title>
          <source>Circulation</source>
          <date>
            <year>2003</year>
          </date>
          <fpage>2201</fpage>
          <lpage>6</lpage>
          <issue>17</issue>
          <volume>107</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Marchionni</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fattirolli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fumagalli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Oldridge</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Del Lungo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Morosi</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B56">
        <mixed-citation>56. Oldridge NB, Guyatt G, Fischer M, Rimm AA. Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA. 1988; 260: 945-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials</article-title>
          <source>JAMA</source>
          <date>
            <year>1988</year>
          </date>
          <fpage>945</fpage>
          <lpage>50</lpage>
          <volume>260</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Oldridge</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Guyatt</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rimm</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B57">
        <mixed-citation>57. O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989; 80: 234-44.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>An overview of randomized trials of rehabilitation with exercise after myocardial infarction</article-title>
          <source>Circulation</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>234</fpage>
          <lpage>44</lpage>
          <volume>80</volume>
          <person-group person-group-type="author">
            <name>
              <surname>O'Connor</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Buring</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Yusuf</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Goldhaber</surname>
              <given-names>SZ</given-names>
            </name>
            <name>
              <surname>Olmstead</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Paffenbarger</surname>
              <given-names>RS Jr</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B58">
        <mixed-citation>58. Griffin KL, Laughlin MH, Parker JL. Exercise training improves endothelium mediated vasorelaxation after chronic coronary occlusion. J Appl Physiol. 1999; 87: 1948-56.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise training improves endothelium mediated vasorelaxation after chronic coronary occlusion</article-title>
          <source>J Appl Physiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1948</fpage>
          <lpage>56</lpage>
          <volume>87</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Griffin</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Laughlin</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B59">
        <mixed-citation>59. Rush JW, Denniss SG, Graham DA. Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity. Can J Appl Physiol. 2005; 30 (4): 442-74.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Vascular nitric oxide and oxidative stress: determinants of endothelial adaptations to cardiovascular disease and to physical activity</article-title>
          <source>Can J Appl Physiol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>442</fpage>
          <lpage>74</lpage>
          <issue>4</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rush</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Denniss</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Graham</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B60">
        <mixed-citation>60. Laufs U, Wassmann S, Czech T, M&#252;nzel T, Eisenhauer M, B&#246;hm M, et al. Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis. Arterioscler Thromb Vasc Biol. 2005; 25: 809-14.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis</article-title>
          <source>Arterioscler Thromb Vasc Biol</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>809</fpage>
          <lpage>14</lpage>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Laufs</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Wassmann</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Czech</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>M&#252;nzel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Eisenhauer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>B&#246;hm</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B61">
        <mixed-citation>61. Roberts K, Barnard RJ, Jasman A, Balon TW. Acute exercise increase nitric oxide synthase activity in skeletal muscle. Am J Physiol. 1999; 277: 390-4.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Acute exercise increase nitric oxide synthase activity in skeletal muscle</article-title>
          <source>Am J Physiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>390</fpage>
          <lpage>4</lpage>
          <volume>277</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Roberts</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Barnard</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Jasman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Balon</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B62">
        <mixed-citation>62. Sun MW, Zhong MF, Gu J, Qian FL, Gu JZ, Chen H. Effects of different levels of exercise volume on endothelium-dependent vasodilation: roles of nitric oxide synthase and heme oxygenase. Hypertens Res. 2008; 31 (4): 805-16.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of different levels of exercise volume on endothelium-dependent vasodilation: roles of nitric oxide synthase and heme oxygenase</article-title>
          <source>Hypertens Res</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>805</fpage>
          <lpage>16</lpage>
          <issue>4</issue>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Zhong</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>JZ</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B63">
        <mixed-citation>63. Duncker DJ, Bache RJ. Regulation of coronary blood flow during exercise. Physiol Rev. 2008; 88 (3): 1009-86.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Regulation of coronary blood flow during exercise</article-title>
          <source>Physiol Rev</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1009</fpage>
          <lpage>86</lpage>
          <issue>3</issue>
          <volume>88</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Duncker</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Bache</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B64">
        <mixed-citation>64. Shen W, Zhang X, Wolin MS, Sessa W, Hintze TH. Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise. Med Sci Sports Exerc. 1995; 8: 1125-34.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>1125</fpage>
          <lpage>34</lpage>
          <volume>8</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wolin</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Sessa</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Hintze</surname>
              <given-names>TH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B65">
        <mixed-citation>65. Taddei S, Galetta F, Virdis A, Ghiadoni L, Salvetti G, Franzoni F, et al. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation. 2000; 101: 2896-901.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes</article-title>
          <source>Circulation</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>2896</fpage>
          <lpage>901</lpage>
          <volume>101</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Taddei</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Galetta</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Virdis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ghiadoni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Salvetti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Franzoni</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B66">
        <mixed-citation>66. Griffin KL, Woodman CR, Price EM, Laughlin MH, Parker JL. Endotheliummediated relaxation of porcine collateral-dependent arterioles is improved by exercise training. Circulation. 2001; 104: 1393-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Endotheliummediated relaxation of porcine collateral-dependent arterioles is improved by exercise training</article-title>
          <source>Circulation</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>1393</fpage>
          <lpage>8</lpage>
          <volume>104</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Griffin</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Woodman</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Price</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Laughlin</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B67">
        <mixed-citation>67. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest. 2000; 105: 1631-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training</article-title>
          <source>J Clin Invest</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1631</fpage>
          <lpage>9</lpage>
          <volume>105</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fukai</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Siegfried</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Ushio-Fukai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kojda</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Harrison</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B68">
        <mixed-citation>68. Yoshinaga K, Beanlands RSB, DeKemp RA, Lortie M, Morin J, Aung M, et al. Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease. Am Heart J. 2006; 151: 1324.e18</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of exercise training on myocardial blood flow in patients with stable coronary artery disease</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>1324.e18</fpage>
          <volume>151</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Yoshinaga</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Beanlands</surname>
              <given-names>RSB</given-names>
            </name>
            <name>
              <surname>DeKemp</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Lortie</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aung</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B69">
        <mixed-citation>69. Niebauer J, Hambrecht R, Marburger C, Hauer K, Velich T, Von Hodenberg E, et al. Impact of intensive physical exercise and low-fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease. Am J Cardiol. 1995; 76 (11): 771-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impact of intensive physical exercise and low-fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease</article-title>
          <source>Am J Cardiol</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>771</fpage>
          <lpage>5</lpage>
          <issue>11</issue>
          <volume>76</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Niebauer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hambrecht</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Marburger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hauer</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Velich</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Von Hodenberg</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B70">
        <mixed-citation>70. Linke A, M&#246;bius-Winkler S, Hambrecht R. Exercise training in the treatment of coronary artery disease and obesity. Herz. 2006; 31 (3): 224-33.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise training in the treatment of coronary artery disease and obesity</article-title>
          <source>Herz</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>224</fpage>
          <lpage>33</lpage>
          <issue>3</issue>
          <volume>31</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Linke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>M&#246;bius-Winkler</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hambrecht</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B71">
        <mixed-citation>71. Hilberg T. Physical activity in the prevention of cardiovascular diseases: epidemiology and mechanisms. Hamostaseologie. 2008; 28 (1): 9-15.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Physical activity in the prevention of cardiovascular diseases: epidemiology and mechanisms</article-title>
          <source>Hamostaseologie</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>9</fpage>
          <lpage>15</lpage>
          <issue>1</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hilberg</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B72">
        <mixed-citation>72. Gunning MG, Walker J, Eastick S, Bomanji JB, Ell PJ, Walker JM. Exercise training following myocardial infarction improves myocardial perfusion assessed by thallium-201 scintigraphy. Int J Cardiol. 2002; 84 (2-3): 233-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise training following myocardial infarction improves myocardial perfusion assessed by thallium-201 scintigraphy</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>233</fpage>
          <lpage>9</lpage>
          <issue>2-3</issue>
          <volume>84</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Gunning</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Eastick</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bomanji</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Ell</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B73">
        <mixed-citation>73. Reinhart WH, Dziekan G, Goebbels U, Myers J, Dubach P. Influence of exercise training on blood viscosity in patients with coronary artery disease and impaired left ventricular function. Am Heart J. 1998; 135 (3): 379-82.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Influence of exercise training on blood viscosity in patients with coronary artery disease and impaired left ventricular function</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1998</year>
          </date>
          <fpage>379</fpage>
          <lpage>82</lpage>
          <issue>3</issue>
          <volume>135</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Reinhart</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Dziekan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Goebbels</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dubach</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B74">
        <mixed-citation>74. Letcher RL, Pickering TG, Chien S, Laragh JH. Effects of exercise on plasma viscosity in athletes and sedentary normal subjects. Clin Cardiol. 1981; 4 (4): 172-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effects of exercise on plasma viscosity in athletes and sedentary normal subjects</article-title>
          <source>Clin Cardiol</source>
          <date>
            <year>1981</year>
          </date>
          <fpage>172</fpage>
          <lpage>9</lpage>
          <issue>4</issue>
          <volume>4</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Letcher</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Pickering</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Laragh</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B75">
        <mixed-citation>75. El-Sayed MS, Ali N, El-Sayed Ali Z. Haemorheology in exercise and training. Sports Med. 2005; 35 (8): 649-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Haemorheology in exercise and training</article-title>
          <source>Sports Med</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>649</fpage>
          <lpage>70</lpage>
          <issue>8</issue>
          <volume>35</volume>
          <person-group person-group-type="author">
            <name>
              <surname>El-Sayed</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>El-Sayed Ali</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B76">
        <mixed-citation>76. Ernst E, Matrai A, Aschenbrenner E. Blood rheology in athletes. J Sports Med Phys Fitness. 1985; 25 (4): 207-10.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Blood rheology in athletes</article-title>
          <source>J Sports Med Phys Fitness</source>
          <date>
            <year>1985</year>
          </date>
          <fpage>207</fpage>
          <lpage>10</lpage>
          <issue>4</issue>
          <volume>25</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ernst</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Matrai</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aschenbrenner</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B77">
        <mixed-citation>77. Charm SE, Paz H, Kurland GS. Reduced plasma viscosity among joggers compared with non-joggers. Biorheology. 1979; 16 (3): 185-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Reduced plasma viscosity among joggers compared with non-joggers</article-title>
          <source>Biorheology</source>
          <date>
            <year>1979</year>
          </date>
          <fpage>185</fpage>
          <lpage>9</lpage>
          <issue>3</issue>
          <volume>16</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Charm</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Paz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kurland</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B78">
        <mixed-citation>78. Bacon SL, Ring C, Hee FL, Lip GY, Blann AD, Lavoie KL, et al. Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients. Biol Psychol. 2006; 71 (2): 162-70.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Hemodynamic, hemostatic, and endothelial reactions to psychological and physical stress in coronary artery disease patients</article-title>
          <source>Biol Psychol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>162</fpage>
          <lpage>70</lpage>
          <issue>2</issue>
          <volume>71</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Bacon</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Ring</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hee</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Lip</surname>
              <given-names>GY</given-names>
            </name>
            <name>
              <surname>Blann</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Lavoie</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B79">
        <mixed-citation>79. Feiql EO. Coronary physiology. Physiol Rev. 1983; 63: 1-205.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Coronary physiology</article-title>
          <source>Physiol Rev</source>
          <date>
            <year>1983</year>
          </date>
          <fpage>1</fpage>
          <lpage>205</lpage>
          <volume>63</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Feiql</surname>
              <given-names>EO</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Enfermedad arterial coronaria, ejercicio f&#237;sico y estr&#233;s oxidativo</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>Las enfermedades cardiovasculares (ECV) lideran los &#237;ndices de morbilidad y mortalidad en Brasil y en el mundo, siendo la enfermedad arterial coronaria (EAC) la causa de un gran n&#250;mero de muertes y de gastos en asistencia m&#233;dica. Numerosos factores de riesgo para EAC est&#225;n directamente relacionados a la disfunci&#243;n endotelial. La presencia de estos factores de riesgo induce la disminuci&#243;n de la biodisponibilidad de &#243;xido n&#237;trico (NO), el aumento de la formaci&#243;n de radicales libres (RL) y el aumento de la actividad endotelial. Esos cambios pueden perjudicar la capacidad vasodilatadora. En el tratamiento de la EAC se realizan numerosas intervenciones, incluyendo agentes farmacol&#243;gicos, cambio en los h&#225;bitos alimentarios, suplemento nutricional y ejercicio f&#237;sico regular, cuyos efectos ben&#233;ficos sobre la funci&#243;n endotelial han sido demostrados en experimentos con animales y humanos. Sin embargo, la literatura es a&#250;n controvertida en cuanto a la intensidad de esfuerzo necesaria para provocar alteraciones protectoras significativas en la funci&#243;n endotelial. De la misma forma, los ejercicios intensos est&#225;n tambi&#233;n relacionados al aumento en el consumo de ox&#237;geno y al consiguiente aumento en la formaci&#243;n de radicales libres de oxigeno (RLO).</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>Enfermedad de la arteria coronaria</kwd>
        <kwd>ejercicio</kwd>
        <kwd>endotelio vascular</kwd>
        <kwd>radicales libres</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO DE REVISI&#211;N</bold>
      </p>
      <p>
        <fn id="top-body2">
          <label>
            <bold>Enfermedad arterial coronaria, ejercicio f&#237;sico y estr&#233;s oxidativo</bold>
          </label>
          <p>
            <bold>Ricardo Aurino de Pinho<sup>I</sup>; Mar&#237;lia Costa de Ara&#250;jo<sup>I</sup>; Gabriela Lima de Melo Ghisi<sup>II</sup>; Magnus Benetti<sup>II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Universidade do Extremo Sul Catarinense</p>
      <p><sup>II</sup>Universidade do Estado de Santa Catarina, Crici&#250;ma, SC - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p>Las enfermedades cardiovasculares (ECV) lideran los &#237;ndices de morbilidad y mortalidad en Brasil y en el mundo, siendo la enfermedad arterial coronaria (EAC) la causa de un gran n&#250;mero de muertes y de gastos en asistencia m&#233;dica. Numerosos factores de riesgo para EAC est&#225;n directamente relacionados a la disfunci&#243;n endotelial. La presencia de estos factores de riesgo induce la disminuci&#243;n de la biodisponibilidad de &#243;xido n&#237;trico (NO), el aumento de la formaci&#243;n de radicales libres (RL) y el aumento de la actividad endotelial. Esos cambios pueden perjudicar la capacidad vasodilatadora. En el tratamiento de la EAC se realizan numerosas intervenciones, incluyendo agentes farmacol&#243;gicos, cambio en los h&#225;bitos alimentarios, suplemento nutricional y ejercicio f&#237;sico regular, cuyos efectos ben&#233;ficos sobre la funci&#243;n endotelial han sido demostrados en experimentos con animales y humanos. Sin embargo, la literatura es a&#250;n controvertida en cuanto a la intensidad de esfuerzo necesaria para provocar alteraciones protectoras significativas en la funci&#243;n endotelial. De la misma forma, los ejercicios intensos est&#225;n tambi&#233;n relacionados al aumento en el consumo de ox&#237;geno y al consiguiente aumento en la formaci&#243;n de radicales libres de oxigeno (RLO).</p>
      <p><bold>Palabras clave:</bold> Enfermedad de la arteria coronaria, ejercicio, endotelio vascular, radicales libres.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>La enfermedad arterial coronaria (EAC) se caracteriza por la insuficiente irrigaci&#243;n sangu&#237;nea del coraz&#243;n por las arterias coronarias. Est&#225; directamente relacionada al grado de obstrucci&#243;n del flujo sangu&#237;neo por las placas ateroscler&#243;ticas, resultando en un estrechamiento de las arterias coronarias (estenosis), que, debido a la reducci&#243;n del flujo sangu&#237;neo coronario<sup>1</sup>, disminuye la llegada del ox&#237;geno al coraz&#243;n.</p>
      <p>Las enfermedades cardiovasculares (ECV) lideran los &#237;ndices de morbilidad y mortalidad en Brasil y en el mundo, siendo la EAC la causa de un gran n&#250;mero de muertes y de gastos en asistencia m&#233;dica<sup>2,3</sup>. En Brasil, seg&#250;n la S&#237;ntesis de Indicadores Sociales de 2002, realizada por el Instituto Brasile&#241;o de Geograf&#237;a y Estad&#237;stica (IBGE), las ECV se destacan como la principal causa de muerte en el pa&#237;s (un 28,8% para hombres y un 36,9% para mujeres), en todas las regiones y estados. La regi&#243;n Sur y el estado de Rio Grande do Sul, en particular, registran las mayores proporciones, y son responsables del 40% de las muertes de mujeres<sup>3</sup>. El tabaquismo, la obesidad, la <italic>diabetes mellitus</italic>, la hipertensi&#243;n, los niveles elevados de colesterol, los antecedentes familiares de EAC y la falta de ejercicios aumentan el riesgo de la enfermedad<sup>1,2</sup>.</p>
      <p>Hermann y Lerman<sup>4</sup> sugieren que varios factores de riesgo para la EAC est&#225;n directamente relacionados a la disfunci&#243;n endotelial. La presencia de esos factores de riesgo causa un gran n&#250;mero de cambios perjudiciales para la biolog&#237;a vascular, incluyendo la disminuci&#243;n de la biodisponibilidad de &#243;xido n&#237;trico (NO), aumento de la formaci&#243;n de radicales libres (RL) y aumento de la actividad endotelial. Estos cambios pueden conducir a un deterioro de la capacidad vasodilatadora<sup>5-7</sup>.</p>
      <p>Para el tratamiento de la EAC, se realizan numerosas intervenciones, incluyendo agentes farmacol&#243;gicos, cambio en los h&#225;bitos alimentarios, suplemento nutricional y ejercicio f&#237;sico regular.</p>
      <p>Para mantener la salud y prevenir numerosas enfermedades, se recomienda ejercicio f&#237;sico leve a moderado, realizado regularmente. Tambi&#233;n reduce la producci&#243;n de oxidantes y la aparici&#243;n de da&#241;os oxidativos, mejorando el sistema de defensa antioxidante y aumentando la resistencia de los &#243;rganos y tejidos contra la acci&#243;n delet&#233;rea de los RL<sup>8</sup>. No obstante, algunos estudios<sup>9-11</sup> presentan evidencias de que el ejercicio f&#237;sico, principalmente el m&#225;s intenso, est&#225; asociado tanto a da&#241;os musculares como a la producci&#243;n elevada de RL.</p>
      <p>Los efectos ben&#233;ficos del ejercicio f&#237;sico regular sobre la funci&#243;n endotelial han sido demostrados en experimentos con animales y humanos<sup>12</sup>. Sin embargo, la literatura sostiene a&#250;n una controversia respecto a la intensidad de esfuerzo necesaria para provocar alteraciones protectoras significativas en la funci&#243;n endotelial. Seg&#250;n Farsifar et al<sup>13</sup> y Wisl&#248;ff et al<sup>14</sup>, ejercicios agudos e intensos presentan una significativa y r&#225;pida respuesta en la funci&#243;n endotelial. No obstante, algunos estudios se&#241;alan que los ejercicios intensos est&#225;n relacionados tambi&#233;n al aumento en el consumo de ox&#237;geno y al consiguiente aumento en la formaci&#243;n de RL en el m&#250;sculo card&#237;aco y esquel&#233;tico<sup>10,11,15</sup>.</p>
      <p>As&#237;, esta revisi&#243;n pretende abordar la disfunci&#243;n endotelial comprometida en la g&#233;nesis de la EAC, enfocando el papel del endotelio vascular, as&#237; como la importancia del ejercicio f&#237;sico sobre la funci&#243;n endotelial y de los par&#225;metros de estr&#233;s oxidativo en la EAC.</p>
      <p>
        <bold>Funci&#243;n endotelial y aterosclerosis</bold>
      </p>
      <p>Se sabe que las caracter&#237;sticas funcionales de las arterias coronarias son determinadas por las c&#233;lulas endoteliales, c&#233;lulas del m&#250;sculo liso vascular y elementos del tejido conectivo en las paredes arteriales. El m&#250;sculo vascular es el final del camino habitual para activar el control del di&#225;metro de las arterias y, por lo tanto, de la resistencia vascular<sup>16-18</sup>.</p>
      <p>Tradicionalmente, se consideraba que el papel del endotelio era, sobre todo, de barrera selectiva para la difusi&#243;n de macromol&#233;culas de la luz de los vasos sangu&#237;neos hacia el espacio intersticial. Durante los &#250;ltimos 20 a&#241;os, no obstante, se definieron muchas otras funciones para el endotelio, como regulaci&#243;n del tono vagal<sup>16</sup>, modulaci&#243;n de la inflamaci&#243;n, promoci&#243;n e inhibici&#243;n del crecimiento neovascular<sup>17</sup> y modulaci&#243;n de la agregaci&#243;n plaquetaria y de la coagulaci&#243;n<sup>16-18</sup>. Adicionalmente, el endotelio es responsable de la s&#237;ntesis de factores vasoconstrictores y vasodilatadores, entre los que el NO es uno de los factores relajantes de mayor importancia<sup>19,20</sup>, derivados del endotelio.</p>
      <p>En condiciones basales, en individuos sanos, hay un tono vasodilatador moderado y constante, causado por el NO endotelial, que se difunde hacia las c&#233;lulas de la musculatura lisa vascular; si la producci&#243;n basal de NO cesa, aparecer&#225; vasoconstricci&#243;n. La baja producci&#243;n de NO (en varias enfermedades vasculares) reduce la perfusi&#243;n tisular y promueve la formaci&#243;n de trombos, mientras que la alta producci&#243;n produce una vasodilataci&#243;n pronunciada y shock<sup>21</sup>.</p>
      <p>Diversas enfermedades, como las dislipidemias, la aterosclerosis y la hipertensi&#243;n arterial sist&#233;mica (HAS) presentan, en su g&#233;nesis y/o en sus mecanismos fisiopatol&#243;gicos, alteraciones en la funci&#243;n endotelial. As&#237;, la disfunci&#243;n endotelial, caracterizada por una menor producci&#243;n y/o biodisponibilidad de NO, es uno de los factores que contribuyen a la aparici&#243;n de las ECV<sup>20,22</sup>.</p>
      <p>La comprensi&#243;n de la g&#233;nesis y progresi&#243;n de la aterosclerosis ha sido un factor fuertemente esclarecedor en la &#250;ltima d&#233;cada. A mediados de la d&#233;cada de 1970, Ross y Glomaser<sup>23</sup> sugirieron que la aterosclerosis coronaria comienza con una injuria en la pared arterial, que lleva a un desnudamiento del endotelio o a la descamaci&#243;n del revestimiento endotelial de la arteria. Complementando esta hip&#243;tesis, evidencias recientes sugieren que a&#250;n las cl&#225;sicas manchas de grasa - la primera lesi&#243;n com&#250;n en la infancia - son una lesi&#243;n inflamatoria constituida de macr&#243;fagos, monocitos derivados y linfocitos -T<sup>24</sup>.</p>
      <p>En personas sin aterosclerosis, el efecto predominante de la activaci&#243;n endotelial y liberaci&#243;n de NO es la vasodilataci&#243;n. La lesi&#243;n endotelial y el desnudamiento resultan en la disfunci&#243;n (vasoconstricci&#243;n paradojal en respuesta a agentes vasodilatadores), que parece ser el evento inicial para el desarrollo de la aterosclerosis. La disfunci&#243;n endotelial precede a la aparici&#243;n f&#237;sica de la aterosclerosis en la angiograf&#237;a<sup>25</sup>. El conocimiento creciente de que el di&#225;metro de la luz de las coronarias del epicardio, de los vasos de resistencia y de las arterias perif&#233;ricas mayores est&#225; alterado, en respuesta a los factores mediados por flujo y mediados por agonista (NO y endotelio-1), ha contribuido a la comprensi&#243;n de la aterosclerosis. Ludmer et al<sup>26</sup> y El-Tamimi et al<sup>27</sup> primero observaron una vasoconstricci&#243;n parad&#243;jica de segmentos ateroscler&#243;ticos de arterias coronarias en respuesta a la infusi&#243;n de acetilcolina.</p>
      <p>Se entiende, por lo tanto, que el da&#241;o endotelial y su disfunci&#243;n son eventos iniciales de la aterosclerosis. Adicionalmente, la disfunci&#243;n endotelial se reconoce tambi&#233;n como factor importante en el s&#237;ndrome coronario agudo (SCA)<sup>7,18,28</sup>. Rozanski et al<sup>29</sup> compararon la respuesta del flujo sangu&#237;neo perif&#233;rico en 57 pacientes con enfermedad coronaria y en 50 sujetos aparentemente saludables, como grupo control. Los dos grupos fueron sometidos a un ejercicio f&#237;sico en cinta ergom&#233;trica, y los resultados revelaron que no existe ninguna manifestaci&#243;n de vasodilataci&#243;n inducida por el ejercicio en el grupo control. En contrapartida, 53% de los sujetos con enfermedad coronaria demostraron una vasoconstricci&#243;n progresiva.</p>
      <p>El endotelio, cuando es agredido por factores de riesgo, pierde progresivamente su funci&#243;n fisiol&#243;gica de protecci&#243;n, pasando a ser fuente de elementos que participan en la progresi&#243;n de la aterosclerosis. Estos da&#241;os o activaci&#243;n del endotelio modifican funciones reguladoras, lo que resulta en una disfunci&#243;n endotelial, altera la respuesta vasodilatadora y reduce la actividad antitromb&#243;tica, ocasionando alteraciones estructurales y, obviamente, da&#241;o vascular<sup>6,7,30,31</sup>.</p>
      <p>Por lo tanto, la aterosclerosis es el prototipo de la enfermedad caracterizada, en todas sus fases, por una disfunci&#243;n endotelial, que se define como una oferta insuficiente de NO, causante de estr&#233;s oxidativo, inflamaci&#243;n, erosi&#243;n y vasoconstricci&#243;n<sup>4</sup>.</p>
      <p>Entre los factores que causan da&#241;o al endotelio, las especies reactivas de ox&#237;geno (ERO) y las especies reactivas (ERN) - espec&#237;ficamente las derivadas del NO -, son cada vez m&#225;s reconocidas como las principales responsables por comprometer la funci&#243;n endotelial celular y por su implicancia en la aterog&#233;nesis<sup>7</sup>.</p>
      <p>
        <bold>Especies reactivas de ox&#237;geno y estr&#233;s oxidativo en la EAC</bold>
      </p>
      <p>Bajo condiciones fisiol&#243;gicas normales, la mayor&#237;a de las ERO se produce en la cadena respiratoria mitocondrial, donde del 2% al 5% de los electrones son desviados para la producci&#243;n de RL. Adicionalmente, las ERO pueden ser generadas en otros eventos bioqu&#237;micos en la c&#233;lula, como, por ejemplo, en procesos inflamatorios, en el catabolismo de &#225;cidos grasos, en la degradaci&#243;n de la xantina a &#225;cido &#250;rico y auto-oxidaci&#243;n de catecolaminas<sup>32</sup>. Aunque estos procesos sean normales para la vida de las c&#233;lulas, la producci&#243;n excesiva de ERO puede provocar da&#241;os a biomol&#233;culas, (como &#225;cidos nucleicos, prote&#237;nas y l&#237;pidos) los que, en gran extensi&#243;n, pueden llevar a la muerte celular<sup>32</sup>.</p>
      <p>La producci&#243;n de RL no siempre es perjudicial para el organismo; por el contrario, es necesaria en varios procesos biol&#243;gicos, como se&#241;alizaci&#243;n celular, contracci&#243;n muscular y sistema inmunol&#243;gico<sup>33</sup>. Por ejemplo, cuando las c&#233;lulas son agredidas por alg&#250;n agente estresante (que tambi&#233;n puede ser RL), terminan produciendo RL para combatir esos agentes. El gran problema es que, cuando los niveles totales generados de RL son mayores que la capacidad de defensa, pueden ocurrir da&#241;os celulares significativos.</p>
      <p>El aumento del estr&#233;s oxidativo puede contribuir a la patog&#233;nesis de enfermedades cardiovasculares<sup>2,6,7</sup>. Estudios cl&#237;nicos experimentales han sugerido que estas enfermedades est&#225;n asociadas al aumento de la formaci&#243;n de radicales libres y a la reducci&#243;n de las defensas antioxidantes<sup>2,6,34</sup>.</p>
      <p>En la pared vascular, diferentes oxidantes pueden originarse a partir de fuentes celulares y extracelulares y de rutas enzim&#225;ticas y no enzim&#225;ticas. Las principales fuentes de RL en la pared vascular inflamada, con aceptable relevancia fisiol&#243;gica en las ECV, son: NADPH oxidasa, &#243;xido n&#237;trico sintasa endotelial (eNOS) desacoplada y &#243;xido n&#237;trico sintasa inducible (iNOS); mieloperoxidasa, xantina oxidasa (XO), lipoxigenasa/ciclooxigenasa y cadena respiratoria/fosforilaci&#243;n oxidativa<sup>2,7,35</sup>.</p>
      <p>Actualmente, el mecanismo m&#225;s importante, por el cual se cree que el estr&#233;s oxidativo altera la funci&#243;n endotelial es la inactivaci&#243;n del NO por los aniones super&#243;xidos y lipoprote&#237;nas de baja densidad oxidadas (LDLs-ox). Estos RL desactivan los receptores endoteliales para acetilcolina, serotonina, trombina, bradiquinina y otros mediadores, disminuyendo la estimulaci&#243;n de la NOS en las c&#233;lulas endoteliales y, consiguientemente, reduciendo la producci&#243;n de NO, perjudicando la relajaci&#243;n de las c&#233;lulas musculares lisas y predisponiendo a la formaci&#243;n de la placa ateroscler&#243;tica<sup>6</sup>.</p>
      <p>Adem&#225;s, la producci&#243;n de ERO puede reaccionar con la mol&#233;cula de NO y producir el ani&#243;n peroxinitrito (ONOO<sup>-</sup>) y di&#243;xido de nitr&#243;geno, iniciando as&#237; la peroxidaci&#243;n lip&#237;dica y potencializando la lesi&#243;n inflamatoria en c&#233;lulas vasculares, disminuyendo la disponibilidad de NO para las c&#233;lulas y favoreciendo los procesos tromboemb&#243;licos<sup>2,35</sup>.</p>
      <p>La modificaci&#243;n oxidativa de lipoprote&#237;nas circulatorias por RL, particularmente las lipoprote&#237;nas de baja densidad (LDL), parece ser bastante importante para el desarrollo de lesiones ateroscler&#243;ticas, principalmente la oxidaci&#243;n de &#225;cidos grasos poliinsaturados en el LDL, que parece ocurrir dentro de las lesiones ateroscler&#243;ticas. Siguiendo el proceso de oxidaci&#243;n, LDL-ox estimula la migraci&#243;n de monocitos circulantes hacia el espacio subendotelial y tambi&#233;n causa lesi&#243;n en la c&#233;lula endotelial. La LDL-ox es capturada entonces por macr&#243;fagos, m&#225;s r&#225;pidamente que lo normal, para formar c&#233;lulas espumosas cargadas de colesterol. Este proceso histol&#243;gico prematuro lleva al desarrollo de placas ateroscler&#243;ticas<sup>6,7,35</sup>.</p>
      <p>Adem&#225;s, la propia LDL-ox es citot&#243;xica para las c&#233;lulas endoteliales. Ella tambi&#233;n promueve la expresi&#243;n de citocinas, es pro-inflamatoria, causa inhibici&#243;n de la eNOS, provoca vasoconstricci&#243;n y adhesi&#243;n y aumenta la agregaci&#243;n plaquetaria<sup>2,7,15</sup>.</p>
      <p>Factores de riesgo para aterosclerosis, como tabaquismo, <italic>diabetes mellitus</italic>, hipertensi&#243;n, hipercolesterolemia y otros, se asocian con el aumento de la producci&#243;n de RL. La producci&#243;n excesiva de ERO promueve la producci&#243;n directa de especies citot&#243;xicas y la inactivaci&#243;n de NO<sup>2,6</sup>. Esa inactivaci&#243;n lleva a la p&#233;rdida de los efectos protectores del NO, como regulaci&#243;n del tono arterial, inhibici&#243;n de la inflamaci&#243;n local y de la coagulaci&#243;n, como tambi&#233;n de la proliferaci&#243;n celular<sup>16-18</sup>.</p>
      <p>El efecto protector del NO en la aterosclerosis ocurre mediante la inhibici&#243;n de la oxidaci&#243;n de las mol&#233;culas de LDL colesterol y del impedimento de la agregaci&#243;n plaquetaria. El mecanismo por el cual el NO impide la formaci&#243;n de la mol&#233;cula de LDL-ox se da por medio de su acci&#243;n antioxidante, impidiendo la formaci&#243;n de aniones super&#243;xidos, que promueven la oxidaci&#243;n de la mol&#233;cula de LDL colesterol<sup>36,37</sup>. La acci&#243;n antiagregante del NO se debe a su uni&#243;n con la mol&#233;cula de guanilatociclasa. Ella induce la formaci&#243;n de guanilato monofosfato c&#237;clico (GMPc), que promueve la reducci&#243;n de la concentraci&#243;n de iones calcio dentro de la plaqueta, inhibiendo su activaci&#243;n y agregaci&#243;n<sup>38</sup>.</p>
      <p>La p&#233;rdida de NO perjudica estos mecanismos protectores, y contribuye al desarrollo de la aterosclerosis. Se cree que el estr&#233;s oxidativo induce a una disfunci&#243;n endotelial en la aterosclerosis coronaria por el aumento de la degradaci&#243;n e inhibici&#243;n de la s&#237;ntesis de NO<sup>12</sup>.</p>
      <p>
        <bold>Ejercicio f&#237;sico y estr&#233;s oxidativo</bold>
      </p>
      <p>Tasas metab&#243;licas elevadas como resultado del ejercicio f&#237;sico pueden aumentar dram&#225;ticamente el consumo de ox&#237;geno (VO<sub>2m&#225;x</sub>) en hasta 20 veces, en relaci&#243;n a los valores de reposo<sup>39</sup>. Ese aumento esta seguido por un concomitante aumento en la producci&#243;n de ERO<sup>40</sup>. Sin embargo, algunos estudios han demostrado que el entrenamiento de <italic>endurance</italic> aumenta las defensas antioxidantes, as&#237; como la capacidad oxidativa del m&#250;sculo<sup>40-42</sup>.</p>
      <p>El estr&#233;s oxidativo ha sido asociado a la disminuci&#243;n de la performance, fatiga, da&#241;o muscular y exceso de entrenamiento. Por esa raz&#243;n, algunos investigadores<sup>8,39,41,43</sup> sugieren que reducir el estr&#233;s oxidativo puede mejorar la tolerancia al ejercicio, as&#237; como la performance f&#237;sica.</p>
      <p>Aunque los beneficios del aumento en el VO<sub>2m&#225;x</sub> est&#233;n bien establecidos, se verifica una paradoja bioqu&#237;mica. El aumento en el consumo m&#225;ximo de O<sub>2</sub> es esencial para la aptitud cardiovascular y performance, pero el aumento en el consumo de O<sub>2</sub> durante el ejercicio f&#237;sico provoca un concomitante aumento en la producci&#243;n de RL. Dependiendo del tipo y de la intensidad del ejercicio, se han propuesto varios mecanismos en la generaci&#243;n de ERO, dentro de los cuales se destacan:</p>
      <p><italic>1) Aumento en la producci&#243;n de ani&#243;n super&#243;xido (O<sub>2</sub>&#183;-) en la cadena respiratoria -</italic> una de las principales fuentes de RL durante el ejercicio f&#237;sico es la descarga de electrones que ocurre en la cadena de transporte de electrones. El aumento en el consumo de ox&#237;geno por parte de los tejidos durante el ejercicio intenso, te&#243;ricamente, llevar&#237;a a un aumento proporcional de O<sub>2</sub>&#183;- y, por consiguiente, provocar&#237;a un aumento en la peroxidaci&#243;n de l&#237;pidos mitocondriales, p&#233;rdida de grupos tioles en prote&#237;nas e inactivaci&#243;n de enzimas oxidativas<sup>33</sup>.</p>
      <p><italic>2) Activaci&#243;n de la xantina oxidasa (XO) -</italic> La XO cataliza la degradaci&#243;n del monofosfato de adenosina (AMP) durante el trabajo muscular isqu&#233;mico, llevando al aumento en la producci&#243;n de O<sub>2</sub>&#183;-. Durante la isquemia, el AMP, formado a partir del ATP (trifosfato de adenosina) por la reacci&#243;n de adenilato quinasa, es degradado a hipoxantina. La XO es convertida y, de esta forma, reducida a xantina desidrogenasa durante la isquemia por proteasas intramusculares, las que necesitan Ca<sup>+2</sup>. La XO convierte la hipoxantina a xantina y &#225;cido &#250;rico, usando el ox&#237;geno molecular como receptor de electrones, formando as&#237; el O<sub>2</sub>&#183;-. En condiciones aer&#243;bicas, el ox&#237;geno suficiente asegura que el ATP sea repuesto v&#237;a fosforilaci&#243;n oxidativa mitocondrial y que la hipoxantina y la xantina sean, primeramente, convertidas a &#225;cido &#250;rico por medio de la xantina desidrogenasa. Adem&#225;s, el m&#250;sculo esquel&#233;tico tiene baja actividad de la XO. Sin embargo, la XO puede ser un importante camino cuando el m&#250;sculo presenta un d&#233;ficit de adenina dinucle&#243;tido. Esta situaci&#243;n, te&#243;ricamente, puede ocurrir durante la isquemia, ejercicio isom&#233;trico, d&#233;ficit de O<sub>2</sub> y ejercicios con limitaci&#243;n vascular de flujo sangu&#237;neo<sup>44</sup>.</p>
      <p><italic>3) Activaci&#243;n de c&#233;lulas polimorfonucleares -</italic> Las c&#233;lulas fagoc&#237;ticas, principalmente neutr&#243;filos y macr&#243;fagos, realizan un r&#225;pido consumo de ox&#237;geno, proceso conocido como <italic>respiratory burst</italic>. Este proceso constituye una de las fuentes de formaci&#243;n de super&#243;xido, per&#243;xido de hidr&#243;geno, radical hidroxilo, &#225;cido hipocloroso y peroxinitrito<sup>45</sup>. Adem&#225;s de presentar una acci&#243;n antitumoral, algunos de estos intermediarios reactivos derivados del ox&#237;geno participan directamente en la defensa del hu&#233;sped contra bacterias, virus, protozoarios y hongos<sup>33</sup>.</p>
      <p>El <italic>respiratory burst</italic> resulta de la actividad de la NADPH oxidasa, una enzima que cataliza la transferencia de electrones de la NADPH al O<sub>2</sub> formando super&#243;xido. En presencia de la super&#243;xido dismutasa (SOD), el super&#243;xido se dismuta, formando un importante agente microbicida, el per&#243;xido de hidr&#243;geno<sup>45</sup>. El per&#243;xido de hidr&#243;geno puede ser catalizado por la mieloperoxidasa, presente principalmente en los neutr&#243;filos, dando origen a una toxina a&#250;n m&#225;s potente en su acci&#243;n microbicida, denominada &#225;cido hipocloroso (HOCl)<sup>46</sup>.Una vez formado, el HOCl tiende a oxidar amino&#225;cidos y sintetizar cloraminas. Estos &#250;ltimos derivados pierden Cl- y CO<sub>2</sub>, formando aminas que son hidrolizadas para producir aldeh&#237;dos. En el caso de la treonina, el hidroxialdeh&#237;do resultante sufre una deshidrataci&#243;n y origina la acrole&#237;na (substancia cancer&#237;gena que destruye fibras el&#225;sticas e irrita mucosas)<sup>46</sup>. El HOCl reacciona a&#250;n con el per&#243;xido de hidr&#243;geno, formando ox&#237;geno singlet (1O<sub>2</sub>). Existe a&#250;n la posibilidad de formar radical hidroxilo (&#183;OH) mediante la reacci&#243;n de Haber-Weiss<sup>32</sup>.</p>
      <p>La neutrofilia inducida por el ejercicio ocurre como resultado de la migraci&#243;n de neutr&#243;filos provenientes de los tejidos endoteliales (mediada por catecolaminas) y de la m&#233;dula &#243;sea (mediada por el cortisol)<sup>47</sup>. Esto produce la remoci&#243;n de prote&#237;nas y c&#233;lulas da&#241;adas y muertas. A&#250;n cuando se trata de una reacci&#243;n deseable, si no est&#225; bien regulada, puede ser una de las causas de inflamaciones agudas. Ello ocurre debido a un gran aumento en la producci&#243;n de mediadores proinflamatorios (interleuquinas 1, 8, TNF-alfa) y prostaglandinas, que lleva a la inducci&#243;n y a la intensificaci&#243;n de un proceso inflamatorio adicional, aumentando la producci&#243;n de ERO (activadores del factor de transcripci&#243;n NF-kB)<sup>48</sup>.</p>
      <p>No obstante, aunque el ejercicio intenso induzca a una alteraci&#243;n significativa en la producci&#243;n de ERO, estudios recientes muestran que el ejercicio f&#237;sico regular de <italic>endurance</italic> puede tornar m&#225;s eficiente el sistema de defensa antioxidante y mejorar la capacidad oxidativa de los sistemas org&#225;nicos, estableciendo un equilibrio entre los da&#241;os inducidos por las ERO y los sistemas de reparaci&#243;n antioxidantes<sup>39-43</sup>.</p>
      <p>
        <bold>Ejercicio f&#237;sico y endotelio</bold>
      </p>
      <p>Numerosos estudios indican que ejercicios moderados a intensos se asocian con una reducci&#243;n significativa en la incidencia de eventos cardiovasculares, posicionando al ejercicio f&#237;sico como una importante modalidad terap&#233;utica en la prevenci&#243;n y pron&#243;stico de estas enfermedades<sup>49,50</sup>. En los &#250;ltimos a&#241;os, se han referido diversos beneficios del ejercicio regular para portadores de cardiopat&#237;a, adem&#225;s de la mejora en la capacidad funcional<sup>51</sup>.</p>
      <p>Realizar ejercicio constituye un estr&#233;s fisiol&#243;gico para el organismo, en funci&#243;n del gran aumento de la demanda energ&#233;tica en relaci&#243;n al reposo, lo que provoca gran liberaci&#243;n de calor e intensa modificaci&#243;n del ambiente qu&#237;mico muscular y sist&#233;mico. Consiguientemente, la exposici&#243;n regular al ejercicio a lo largo del tiempo (entrenamiento f&#237;sico) promueve un conjunto de adaptaciones morfol&#243;gicas y funcionales que confieren mayor capacidad al organismo para responder al estr&#233;s proporcionado por el ejercicio. Es importante destacar que los efectos cr&#243;nicos del ejercicio dependen, fundamentalmente, de una adaptaci&#243;n perif&#233;rica, que comprende tanto un mejor control y distribuci&#243;n del flujo sangu&#237;neo como adaptaciones espec&#237;ficas de la musculatura esquel&#233;tica<sup>52</sup>.</p>
      <p>Gran parte de los pacientes con ECV establecida refiere disminuci&#243;n de la capacidad funcional, que se relaciona con reducci&#243;n del VO<sub>2m&#225;x</sub> obtenido durante la realizaci&#243;n del test ergoespirom&#233;trico. En estos pacientes, la capacidad de ejercicio est&#225; determinada por la compleja interacci&#243;n entre los sistemas cardiovascular, respiratorio, metab&#243;lico y muscular, sumada a la modulaci&#243;n por el sistema nervioso aut&#243;nomo (SNA). De esta forma, cualquier desequilibrio en esta interacci&#243;n puede disminuir la capacidad funcional del individuo<sup>53</sup>.</p>
      <p>El conocimiento que involucra la relaci&#243;n entre ejercicio f&#237;sico y la prevenci&#243;n primaria y secundaria de la EAC ha sido ya ampliamente discutido, y los resultados de numerosos estudios muestran el impacto del ejercicio f&#237;sico en el tratamiento de esta patolog&#237;a<sup>54,55</sup>. Entre muchos estudios, puede destacarse dos meta-an&#225;lisis que confirmaron una importante reducci&#243;n del 20% al 25% en la mortalidad por ECV en pacientes sometidos a rehabilitaci&#243;n card&#237;aca<sup>56,57</sup>.</p>
      <p>Estudios en seres humanos y en animales de laboratorio muestran que el <italic>shear stress</italic> (fuerza que ejerce la sangre sobre la pared de las arterias), inducido por el ejercicio f&#237;sico, es un poderoso est&#237;mulo para la liberaci&#243;n de factores vaso-relajantes producidos por el endotelio vascular, como el NO. Qued&#243; demostrado que el entrenamiento f&#237;sico moderado aumenta la relajaci&#243;n de la musculatura lisa vascular y no vascular, y que esa mayor relajaci&#243;n se debe a la mayor producci&#243;n de NO por las c&#233;lulas endoteliales, en respuesta al ejercicio f&#237;sico<sup>12,58-60</sup>. Adem&#225;s, se observ&#243; que el <italic>shear stress</italic> inducido por el ejercicio f&#237;sico aumenta la expresi&#243;n de la NOS endotelial y neuronal<sup>60-63</sup>.</p>
      <p>As&#237;, durante el ejercicio f&#237;sico, ocurre un aumento del d&#233;bito card&#237;aco y redistribuci&#243;n del flujo sangu&#237;neo hacia la musculatura esquel&#233;tica y la circulaci&#243;n coronaria. Ese mecanismo est&#225; mediado por la eNOS, cuya expresi&#243;n gen&#233;tica puede potenciarse con ejercicios aer&#243;bicos regulares<sup>62,64</sup>.</p>
      <p>Seg&#250;n Taddei et al<sup>65</sup>, el entrenamiento f&#237;sico puede prevenir la disfunci&#243;n endotelial ajustando la disponibilidad de NO consiguiente a la prevenci&#243;n del estr&#233;s oxidativo. Estas evidencias sugieren que el ejercicio f&#237;sico puede prevenir o atenuar la ca&#237;da en la vasodilataci&#243;n endotelio-dependiente.</p>
      <p>De esa forma, los efectos ben&#233;ficos de la pr&#225;ctica de ejercicio regular sobre las ECV se asocian, principalmente, a la mayor producci&#243;n de agentes vasodilatadores derivados del endotelio, con consiguiente reducci&#243;n ln da resistencia vascular perif&#233;rica, disminuci&#243;n de los niveles de LDL colesterol e inhibici&#243;n de la agregaci&#243;n plaquetaria<sup>22,60</sup>.</p>
      <p>Resultados de estudios recientes demuestran que el entrenamiento f&#237;sico provoca mejora significativa en la perfusi&#243;n mioc&#225;rdica<sup>1</sup>. Entre los componentes implicados, pueden citarse:</p>
      <p><italic>1) La funci&#243;n endotelial -</italic> El aumento frecuente de la presi&#243;n transmural en el vaso sangu&#237;neo, a causa del ejercicio repetido, lleva a la mejora en el funcionamiento endotelial, facilitando la perfusi&#243;n mioc&#225;rdica. Este mecanismo de vasodilataci&#243;n, mediado por la acci&#243;n endotelial, se ha descrito como una de las principales adaptaciones vasculares provocadas por el entrenamiento f&#237;sico<sup>49,59,62,66</sup>. Existen, adem&#225;s, estudios con animales que demuestran la mejora en la vaso-relajaci&#243;n del endotelio, debida al ejercicio f&#237;sico<sup>60</sup>.</p>
      <p><italic>2) Velocidad de s&#237;ntesis y de degradaci&#243;n de NO -</italic> En el intento de compensar la formaci&#243;n de peroxinitrito, las c&#233;lulas musculares lisas presentes en el vaso producen una enzima antioxidante, la SOD, que bloquea la acci&#243;n de los RL, disminuyendo de esa forma la degradaci&#243;n del NO. Estudios en animales y en humanos han demostrado que el entrenamiento f&#237;sico aumenta la expresi&#243;n de esta enzima antioxidativa, as&#237; como la producci&#243;n y de la NOS<sup>12,67</sup>.</p>
      <p><italic>3) La microcirculaci&#243;n -</italic> Algunos estudios han lanzado la hip&#243;tesis de que el entrenamiento f&#237;sico tambi&#233;n estimular&#237;a la producci&#243;n de NO en la microcirculaci&#243;n, con la consiguiente acci&#243;n vasodilatadora. Las evidencias muestran que la capacidad vasodilatadora de los vasos de resistencia (microcirculaci&#243;n) se intensifica luego de cuatro semanas de entrenamiento, siendo este hecho de fundamental importancia para la perfusi&#243;n mioc&#225;rdica<sup>59,62,63</sup>. Los resultados del estudio realizado por Yoshinaga et al<sup>68</sup> - que presentan diferencias entre la mejora de las reservas de flujo coronario en segmentos anormales y normales luego del entrenamiento f&#237;sico - reflejan esta acci&#243;n vasodilatadora de la microcirculaci&#243;n. Estos autores creen que las respuestas del ejercicio en la microcirculaci&#243;n son multifactoriales y complejas, y que implican tambi&#233;n la funci&#243;n del m&#250;sculo liso, la funci&#243;n endotelial, la densidad capilar, la regresi&#243;n de la enfermedad y la circulaci&#243;n colateral.</p>
      <p><italic>4) Regresi&#243;n de lesiones arterioscler&#243;ticas -</italic> Algunos estudios demostraron que el ejercicio f&#237;sico, asociado al control de los niveles de colesterol (dieta hipograsa), aten&#250;a la progresi&#243;n de las lesiones coronarias en el largo plazo (cuatro a seis a&#241;os de ejercicio), pudiendo llevar a la regresi&#243;n de la placa arterioscler&#243;tica. Este fen&#243;meno, considerado por muchos controvertido, presenta indiscutiblemente la posibilidad de mejora en la perfusi&#243;n del miocardio<sup>69-71</sup>. Por otro lado, el beneficio del ejercicio f&#237;sico realizado en corto plazo es incierto<sup>72</sup>.</p>
      <p><italic>5) Neoformaci&#243;n de vasos colaterales -</italic> Investigaciones en animales demostraron que el estrechamiento del calibre de las arterias coronarias promueve la aparici&#243;n de circulaci&#243;n colateral, y que este aumento en la circulaci&#243;n se potencia cuando estos animales son sometidos a un programa de ejercicio<sup>70,71</sup>. No obstante, estudios de perfusi&#243;n mioc&#225;rdica con centellograf&#237;a han presentado resultados conflictivos en pacientes coronarios sometidos a un programa regular de ejercicio. Frente a los hechos, se observa que el efecto del entrenamiento en la formaci&#243;n de vasos colaterales es a&#250;n incierto<sup>63,68,69,73</sup>. En modo general, estudios angiogr&#225;ficos en humanos encontraron dificultades para probar el aumento de la circulaci&#243;n colateral en pacientes coronarios sometidos al ejercicio f&#237;sico, hecho que puede ser justificado por la incapacidad de este examen para identificar arterias colaterales de peque&#241;o tama&#241;o (&lt; 100 &#956;m).</p>
      <p><italic>6) Reducci&#243;n de la viscosidad sangu&#237;nea -</italic> El ejercicio f&#237;sico realizado de forma regular provoca un aumento en el volumen plasm&#225;tico, adem&#225;s de reducci&#243;n de algunas prote&#237;nas plasm&#225;ticas, como el fibrin&#243;geno y las globulinas, proceso definido como hemodiluci&#243;n cr&#243;nica<sup>74,75</sup>. A pesar de este aumento del volumen plasm&#225;tico, no existe consenso en relaci&#243;n a la ca&#237;da del hematocrito con el ejercicio cr&#243;nico<sup>75,76</sup>. Paralelamente, ocurre una reducci&#243;n de la viscosidad plasm&#225;tica, que puede alcanzar hasta un 8% en atletas de <italic>endurance</italic><sup>75,77</sup>. Sin embargo, esta disminuci&#243;n de la viscosidad con el ejercicio f&#237;sico no fue demostrada en pacientes coronarios, permaneciendo la duda sobre el real efecto del ejercicio f&#237;sico sobre la viscosidad sangu&#237;nea en estos pacientes<sup>73,78</sup>.</p>
      <p><italic>7) Aumento del tiempo de perfusi&#243;n diast&#243;lica -</italic> En un estudio realizado con pacientes coronarios sometidos a un programa regular de ejercicio f&#237;sico, se observ&#243; disminuci&#243;n de la frecuencia cardiaca basal, con mayor tiempo de perfusi&#243;n diast&#243;lica en reposo. De la misma forma, este aumento del tiempo de perfusi&#243;n diast&#243;lica se manifest&#243; en el pico de ejercicio, atenuando las manifestaciones isqu&#233;micas en el electrocardiograma (ECG)<sup>63,79</sup>.</p>
      <p>Por lo tanto, se sabe claramente que el ejercicio f&#237;sico mejora la capacidad f&#237;sica, la tolerancia al ejercicio y los s&#237;ntomas en pacientes con EAC, reduciendo las tasas de mortalidad. No obstante, los mecanismos bioqu&#237;micos por los que estos beneficios se establecen a&#250;n no est&#225;n completamente comprendidos. A pesar de que la mejora de la funci&#243;n endotelial constituye el fen&#243;meno m&#225;s precoz (de cuatro a seis semanas) del aumento del flujo coronario en individuos entrenados, es precipitado asegurar que este sea el &#250;nico mecanismo implicado en la mejora de la perfusi&#243;n mioc&#225;rdica<sup>1,68</sup>.</p>
      <p>
        <bold>Consideraciones finales</bold>
      </p>
      <p>Frente a lo expuesto, queda claro el papel que el estr&#233;s oxidativo ejerce en la g&#233;nesis y progresi&#243;n de las ECV como la EAC. Entre las numerosas intervenciones terap&#233;uticas empleadas para estas enfermedades, el ejercicio f&#237;sico despunta como una importante herramienta en la manutenci&#243;n y/o recuperaci&#243;n de la funci&#243;n endotelial, siendo sus beneficios bastante documentados en la literatura actual.</p>
      <p>Sin embargo, ser&#225;n necesarios m&#225;s estudios, a fin de que se puedan aclarar todos los mecanismos involucrados en esta acci&#243;n terap&#233;utica. Tambi&#233;n es preciso que se permita un an&#225;lisis de la intensidad de entrenamiento m&#225;s adecuada para estos pacientes, sirviendo de orientaci&#243;n para profesionales que trabajan con prescripci&#243;n y orientaci&#243;n del ejercicio f&#237;sico para individuos con ECV, buscando la reducci&#243;n de la Prevalencia de estas enfermedades en la poblaci&#243;n mundial.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio fue parcialmente financiado por Mutrimental SA y CNPq.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de la tesis de Maestr&#237;a de Mar&#237;lia Costa de Ara&#250;jo por el Programa de postgrado en Ciencias de la Salud de la UNESCO.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Update</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Coronary heart disease, physical exercise and oxidative stress</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>Cardiovascular diseases are the leaders in morbidity and mortality rates in Brazil and worldwide, being coronary heart disease (CHD) the cause of a large number of deaths and high expenditure on medical assistance. Quite a number of risk factors for CHD are directly related to endothelial dysfunction. Those risk factors induce decreased bioavailability of nitric oxide (NO), the increase of free radicals (FR), and increased endothelial activity. Those changes may lead to vasodilation impairment. Many interventions are performed to treat CHD. Pharmacological agents, a change in eating habits, nutritional supplements and physical exercise on a regular basis are some of those interventions. The benefits of physical exercise on a regular basis over endothelial function have been demonstrated in experiments with animals and humans. However, data in the literature are still controversial as to the required intensity level to result in significantly protective changes in endothelial function. Intense exercising is also related to higher oxygen consumption and to a resulting increase of oxygen free radicals (OFR).</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Coronary artery disease</kwd>
        <kwd>exercise</kwd>
        <kwd>endothelium, vascular</kwd>
        <kwd>free radicals</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>REVIEW ARTICLE</bold>
      </p>
      <p><undefined id="add1-body3"/>Coronary heart disease, physical exercise and oxidative stress</p>
      <p>
        <bold>Ricardo Aurino de Pinho<sup>I</sup>; Mar&#237;lia Costa de Ara&#250;jo<sup>I</sup>; Gabriela Lima de Melo Ghisi<sup>II</sup>; Magnus Benetti<sup>II</sup></bold>
      </p>
      <p><sup>I</sup>Universidade do Extremo Sul Catarinense</p>
      <p><sup>II</sup>Universidade do Estado de Santa Catarina, Crici&#250;ma, SC - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p>Cardiovascular diseases are the leaders in morbidity and mortality rates in Brazil and worldwide, being coronary heart disease (CHD) the cause of a large number of deaths and high expenditure on medical assistance. Quite a number of risk factors for CHD are directly related to endothelial dysfunction. Those risk factors induce decreased bioavailability of nitric oxide (NO), the increase of free radicals (FR), and increased endothelial activity. Those changes may lead to vasodilation impairment. Many interventions are performed to treat CHD. Pharmacological agents, a change in eating habits, nutritional supplements and physical exercise on a regular basis are some of those interventions. The benefits of physical exercise on a regular basis over endothelial function have been demonstrated in experiments with animals and humans. However, data in the literature are still controversial as to the required intensity level to result in significantly protective changes in endothelial function. Intense exercising is also related to higher oxygen consumption and to a resulting increase of oxygen free radicals (OFR). </p>
      <p><bold>Key words:</bold> Coronary artery disease; exercise; endothelium, vascular; free radicals.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Coronary heart disease (CHD) is characterized by insufficient blood supply to the heart through coronary arteries. DAC is directly related to the extent of blood flow obstruction by atherosclerotic plaques, with resulting narrowing of the coronary arteries (stenosis), which in its turn reduces the oxygen that reaches the heart due to coronary blood flow reduction<sup>1</sup>.</p>
      <p>Cardiovascular diseases are the leaders in morbidity and mortality rate in Brazil and worldwide, being CHD the cause of a large number of deaths and high expenditure on medical assistance<sup>2,3</sup>. Based on data from the Summary of Social Indicators (2002), collected by the Brazilian Institute of Geography and Statistics (IBGE), cardiovascular diseases stand out as the main cause of death (28.8% among males and 36.9% among females) in the whole country. The Southern Region - and Rio Grande do Sul State in particular - report the highest rates: they account for 40% of deaths among women<sup>3</sup>. Smoking, obesity, diabetes mellitus, hypertension, high cholesterol levels, family history of CHD, and the lack of exercise increase the risk for CHD<sup>1,2</sup>.</p>
      <p>Hermann and Lerman<sup>4</sup> have suggested that a number of risk factors for CHD are directly related to endothelial dysfunction. Those risk factors induce a large number of changes that are damaging to vascular biology, among them a reduction in NO bioavailability, the increase of free radicals, and an increase in endothelial activity. Those changes may lead to vasodilation impairment<sup>5-7</sup>.</p>
      <p>Many interventions are performed to treat CHD. Pharmacological agents, a change in eating habits, nutritional supplements and physical exercise on a regular basis are some of those interventions.</p>
      <p>Mild to moderate physical exercise on a regular basis is recommended for good health and the prevention of a number of diseases. It also reduces the production of oxidants and oxidative damage, improve antioxidant defense system, and increase the resistance of organs and tissues against the deleterious action of FR<sup>8</sup>. However, some studies<sup>9-11</sup> have presented evidence that physical exercise - particularly if too intense - is associated both to muscular damage and high formation of FR. </p>
      <p>The benefits from regular physical exercise over endothelial function have been demonstrated in experiments with animals and humans<sup>12</sup>. The literature is still controversial, however, as to the required exercise intensity to result in significantly protective changes in endothelial function. Farsifar et al<sup>13</sup> and Wisl&#216;ff et al<sup>14</sup> have reported that acute, intense exercising has shown to present significant, fast response on endothelial function. Nonetheless, some studies have demonstrated that intense exercising has also been related to higher oxygen consumption and to resulting increased formation of FR in cardiac and skeletal muscle<sup>10,11,15</sup>.</p>
      <p>Having that in mind, the present review will address the endothelial dysfunction involved in the genesis of CHD. It will focus the role played by vascular endothelium, and the relevance of physical exercise on endothelial function as well as on the parameters of oxidative stress in CHD. </p>
      <p>
        <bold>Endothelial function and atherosclerosis</bold>
      </p>
      <p>It is quite well known that coronary arteries functional characteristics are determined by endothelial cells, vascular smooth muscle cells, and connective tissue elements on arterial walls. The vascular muscle is the end of the regular pathway to activate artery diameter control, and therefore, vascular resistance<sup>16-18</sup>. </p>
      <p>The role played by the endothelium was traditionally thought to be basically that of a selective barrier for the diffusion of macromolecules from blood vessels lumen into the interstitial space. In the last 20 years many other functions have been described for the endothelium, such as the regulation of vagal tonus<sup>16</sup>; inflammation modulation; promotion and inhibition of neovascular growth<sup>17</sup>; and modulation of platelet aggregation and coagulation<sup>16-18</sup>. Additionally, the endothelium is responsible for the synthesis of vasoconstricting and vasodilating factors, being the nitric oxide (NO) one of the most relevant endothelium-derived relaxing factors (EDRF)<sup>19,20</sup>. </p>
      <p>Basal vasodilating tonus in healthy individuals is shown to be moderate and constant from endothelial NO diffusion to vascular smooth muscle cells. If basal formation of NO is interrupted, vasoconstriction occurs. Low NO formation (in a number of vascular diseases) reduces tissue perfusion and promotes the formation of thrombus. High NO formation, however, promotes marked vasodilation and shock<sup>21</sup>.</p>
      <p>A number of diseases - such as dyslipidemia, atherosclerosis, and systemic arterial hypertension - have their genesis and/or their pathophysiological mechanisms in endothelial function. Therefore, endothelial dysfunction - characterized by lower production and/or NO bioavailability - is one of the factors to contribute for the onset of cardiovascular diseases<sup>20,22</sup>.</p>
      <p>The understanding of the genesis and of the progression of atherosclerosis has been highly elucidative in the last decade. In the mid 1970&#180;s, Ross and Glomaser<sup>23</sup> suggested that coronary atherosclerosis starts with an injury in the arterial wall, leading to endothelial denudation or to desquamation of arterial endothelium lining. Adding to that assumption, recent evidence has suggested that even the classic fat spots - the first typical injury in childhood - is an inflammatory injury made of macrophages, derived monocyte-derived, and T-lymphocytes<sup>24</sup>. </p>
      <p>In individuals who do not present atherosclerosis the dominating effect of endothelial activation and NO release is vasodilation. Endothelial injury and denudation result in dysfunction (paradoxical vasoconstriction in response to vasodilating agents) which seems to be the starting event for the development of atherosclerosis. Endothelial dysfunction precedes physical manifestation of atherosclerosis on angiography<sup>25</sup>. Increasing knowledge that coronary lumen diameter in epicardium, in resistance vessels, and in major peripheral arteries is highly dynamic in response to flow-mediated and agonist-mediated factors (NO and endothelium-1) has contributed for the understanding of atherosclerosis. Ludmer et al<sup>26</sup> and El-Tamimi et al<sup>27</sup> were the first to observe paradoxical vasoconstriction of atherosclerotic segments in coronary arteries in response to acetylcholine infusion.</p>
      <p>Therefore, endothelium damage and dysfunction were perceived as the starting events in atherosclerosis. Additionally, endothelial dysfunction has also been recognized as a relevant factor for acute coronary syndrome<sup>7,18,28</sup>. Rozanski et al<sup>29</sup> have compared peripheral blood flow response in 57 patients with coronary heart disease and 50 subjects apparently healthy as controls. Both groups were submitted to physical exercise on the treadmill. Results showed no evidence of vasodilation induction from exercise in the control group, whereas 53% of the coronary heart disease individuals showed progressive vasoconstriction.</p>
      <p>While under aggression by risk factors, endothelium progressively loses its protective, physiologic function, and is turned into a source for elements that are involved in the development of atherosclerosis. Endothelium damage or activation change the regulatory functions and result in endothelial dysfunction, thus changing vasodilating response, reducing antithrombotic activity, and resulting in structural changes and, obviously, vascular damage<sup>6,7,30,31</sup>. </p>
      <p>Therefore, atherosclerosis is the prototype of a disease characterized by endothelial dysfunction at all stages. Endothelial dysfunction is here defined as the insufficient supply of NO, which predisposes to oxidative stress, inflammation, erosion, and vasoconstriction<sup>4</sup>.</p>
      <p>Among the factors that lead to endothelial damage, the Oxygen Reactive Species (ROS) and the Nitrogen Reactive Species (NOS) - specifically those that are NO-derived - have increasingly been recognized as those most responsible for the impairment of cellular endothelial function involved in atherogenesis<sup>7</sup>.</p>
      <p>
        <bold>Reactive oxygen species and oxidative stress in CHD</bold>
      </p>
      <p>Under normal physiologic conditions, most ROS is generated in mitochondrial respiratory chain, where from 2% to 5% of electrons are detoured for the production of free radicals. Additionally, ROS may be generated at other biochemical events in the cells, as for instance during inflammatory processes, fatty acids catabolism, in the degradation of xanthine into uric acid, and in catecholamine auto-oxidation<sup>32</sup>. Although those processes are normal in cell life, excess ROS production may induce damage to biomolecules, among them nucleic acids, proteins, and lipids - which if extensive, may lead to cellular death<sup>32</sup>.</p>
      <p>The generation of free radicals is not always damaging to the body. Quite the opposite, it is necessary for a number of biological processes such as cellular signaling, muscular contraction, and the immune system<sup>33</sup>. When the cells are under the aggression of some stressing agent, for instance (which may also be a free radical), they end up producing free radicals to fight against that agent. A big problem emerges when total level of free radicals generation is higher than defense capabilities, and when significant cellular damage may occur. </p>
      <p>Increased oxidative stress may contribute for the pathogenesis of cardiovascular diseases<sup>2,6,7</sup>. Experimental clinical trials have suggested that those conditions are associated to increased formation of free radicals as well as to the reduction of antioxidant defense<sup>2,6,34</sup>. </p>
      <p>Different oxidants may originate from cellular and extracellular sources, and from enzyme and non-enzyme pathways on the vascular wall. The major sources of free radicals on inflammated vascular wall with acceptable physiologic relevance in cardiovascular diseases are: NADPH oxidase, endothelial nitric oxide synthase (eNOS) uncoupling, and inducible nitric oxide synthase (iNOS), myeloperoxidase, xanthine oxidase, lipoxygenase/cyclooxygenase, respiratory chain/oxidative phosphorilation<sup>2,7,35</sup>.</p>
      <p>Currently, the most important mechanism through which oxidative stress is believed to change endothelial function is through NO inactivation by superoxide anions and oxidated low density lipoproteins (ox-LDLs). Those FR deactivate the endothelial receptors for acetylcholine, serotonin, thrombin, bradicinin, and other mediators, thus reducing NOS stimulation in endothelial cells, with consequent reduction in the production of NO, impairing muscle smooth cells relaxation, and predisposing to atherosclerotic plaque<sup>6</sup>.</p>
      <p>Additionally, the generation of ROS may react with NO molecule and produce peroxinitrite anion (ONOO<sup>-</sup>) and nitrogen dioxide, and therefore start lipid peroxidation and potentialize the inflammatory injury in vascular cells, reducing NO availability and favoring thromboembolic processes<sup>2,35</sup>. </p>
      <p>Oxidative change of circulatory lipoprotein caused by FR - particularly low density lipoproteins (LDL) - seems to be quite relevant in the development of atherosclerotic injuries, primarily the oxidation of polyunsaturated fatty acids in LDL, which seems to occur inside atherosclerotic injuries. Following oxidation process, ox-LDL stimulates the migration of circulating monocytes to the subendothelial space, and also causes endothelial cell injury. ox-LDL is then captured by macrophages - faster than usual - to form cholesterol-loaded foam cells. That early histological process leads to the development of atherosclerotic plaques<sup>6,7,35</sup>.</p>
      <p>Additionally, ox-LDL is cytotoxic to endothelial cells, promotes cytokines expression, is pr-inflammatory, causes eNOS inhibition, promotes vasoconstriction and compliance, and increases platelet aggregation<sup>2,7,15</sup>.</p>
      <p>Risk factors for atherosclerosis - such as smoking, <italic>diabetes mellitus</italic>, hypertension, hypercholesterolemia, and others - are associated to increased formation of FR. Excessive generation of ROS promotes direct generation of cytotoxic species and NO inactivation<sup>2,6</sup>. Such inactivation leads to the loss of NO protective effects such as arterial tonus regulation, inhibition of local inflammation and coagulation, and cellular proliferation<sup>16-18</sup>.</p>
      <p>The protective effect of NO in atherosclerosis occurs through the inhibition of LDL-cholesterol molecules as well as the prevention of platelet aggregation. NO prevents the formation of ox-LDL molecule through its antioxidant action - by preventing the formation of superoxide anions that promote LDL-cholesterol molecule oxidation<sup>36,37</sup>. NO antiaggregating action is a result of its binding to the guanilatocyclase molecule, which induces the formation of cyclic guanilate monophosphate (cGMP), which in its turn promotes the reduction of calcium ions concentration inside the platelet to inhibit its activation and aggregation<sup>38</sup>.</p>
      <p>The loss of NO impairs those protective mechanisms, thus contributing for the development of atherosclerosis. Oxidative stress is believed to induce endothelial dysfunction in coronary atherosclerosis as a result of increased degradation and inhibition of NO synthesis<sup>12</sup>.</p>
      <p>
        <bold>Physical exercise and oxidative stress</bold>
      </p>
      <p>High metabolic rates resulting from physical exercise may drastically increase oxygen consumption (VO<sub>2max</sub>) up to 20 times when compared to values at rest<sup>39</sup>. That increase is followed by a concurrent increase in ROS generation<sup>40</sup>. Studies elsewhere have demonstrated, however, that endurance training increases antioxidating defense, as well as muscle oxidative capacity<sup>40-42</sup>. </p>
      <p>Oxidative stress has been associated to reduced performance, fatigue, muscular damage, and physical exercise in excess. That explains why some researchers<sup>8,39,41,43</sup> have suggested that oxidative stress reduction may improve exercise tolerance as well as physical performance.</p>
      <p>Although the benefits of increased VO<sub>2max</sub> have been quite well established, a biochemical paradox can be observed. Increased maximum consumption of O<sub>2</sub> is crucial for cardiovascular aptitude and performance. Nonetheless, increased consumption of O<sub>2</sub> during physical exercise causes a concurrent increase in FR formation. Depending on exercise type and intensity, different mechanisms for ROS generation have been proposed. Among them, the following should be pointed out:</p>
      <p><italic>1 - Higher generation of superoxide anion (O</italic><sub>2</sub><sup>.</sup>-) in respiratory chain - One of the major sources of free radicals during physical exercise is the release of electrons taking place in electron transport chain. Increased oxygen consumption by the tissues during intense exercise would theoretically lead to a proportional increase of O<sub>2</sub><sup>.</sup>-, consequently leading to increased mitochondrial lipid peroxidation, loss of protein thiol groups, and inactivation of oxidative enzymes<sup>33</sup>.</p>
      <p><italic>2 - Xanthine oxidase (XO) activation - </italic>XO catalyzes adenosine monophostate (AMP) during muscular ischemia, leading to increased O<sub>2</sub><sup>.</sup>- production. During ischemia AMP - formed from adenosine triphosphate (ATP) through adenilate kinase (ADK) reaction - is degraded into hypoxanthine. XO is converted and then reduced to xanthine dehydrogenase during ischemia by intramuscular proteases, which need Ca<sup>+2</sup>. XO converts hypoxanthine to xanthine and uric acid by using molecular oxygen as electrons receptor, thus forming O<sub>2</sub><sup>.</sup>-. Under aerobic conditions, sufficient oxygen will ensure that ATP is replaced via mitochondrial oxidative phosphorylation, and that hypoxanthine and xanthine are first converted to uric acid by xanthine dehydrogenase. Additionally, the skeletal muscle has low XO activity. However, XO may be a relevant pathway when the muscle presents adenine dinucleotide. In theory, that may occur under ischemia, isometric exercises, O<sub>2</sub> deficit, and blood flow vascular limitation while exercising<sup>44</sup>.</p>
      <p><italic>3 - Polymorphonuclear cells activation - </italic>The fast oxygen consumption process by phagocytic cells - particularly neutrophils and macrophages - is known as respiratory burst. That process is one of the sources for superoxide, hydrogen peroxide, hydroxyl radical, hypochloride acid peroxinitrate<sup>45</sup>. In addition to presenting antitumoral action, some of those reactive oxygen intermediates are directly involved in the defense of the host against bacteria, viruses, protozoans, and fungi<sup>33</sup>.</p>
      <p>Respiratory burst results from the activity of NADPH oxidase - an enzyme that catalyzes electrons transfer from NADPH to O<sub>2</sub> to form superoxide. Superoxide dismutation occurs when superoxide dismutase is present, thus forming an important microbicidal agent - hydrogen peroxide<sup>45</sup>. Hydrogen peroxide may be catalyzed by myeloperoxidase - found particularly in neutrophils, resulting in an even more powerful toxin in its microbicidal action called hypochloride acid (HOCl)<sup>46</sup>.</p>
      <p>Once formed, HOCl is bound to oxidize aminoacids to chloramine synthesis. Those last derivatives lose Cl- and CO<sub>2</sub>, thus forming amines that are hydrolized to aldehydes. As for treonin, resulting hydroxyaldehyde undergoes dehydration and produces acrolein (cancerigenous, destroys elastic fibers, irritates mucosae)<sup>46</sup>. HOCl also reacts with hydrogen peroxide to form singlet oxygen (1O<sub>2</sub>). Hydroxyl radical (OH&#183;) may also be formed by Haber-Weiss reaction<sup>32</sup>.</p>
      <p>Exercise-induced neutrophil activation occurs as a result of the migration (catecholamine mediated) of neutrophils from endothelial tissues and bone marrow (cortisol mediated)<sup>47</sup><sub>.</sub> That leads to the removal of damaged proteins and cells, as well as dead cells. Although that is a desirable reaction, if not well regulated it may be one of the causes for acute inflammations due to the largely increased production of pro-inflammatory mediators (interleukin 1, 8, TNF-alpha) and prostaglandins, thus leading to the induction and intensification of additional inflammatory processes and increasing the generation of ROS - NF-kB<sup>48</sup> factor transcription activators.</p>
      <p>However, even if intense exercising induces significant change in ROS generation, recent studies have shown that regular endurance exercise may turn antioxidant defense system more efficient as well as improve the oxidative capacity of organic systems, thus establishing equilibrium between ROS-induced damages and antioxidant repair systems<sup>39-43</sup>. </p>
      <p>
        <bold>Physical exercise and endothelium</bold>
      </p>
      <p>Quite a number of studies have demonstrated that moderate to intense exercising is associated to significant reduction in the incidence of cardiovascular events, thus ranking physical exercise as a relevant therapeutic regimen for the prevention and prognosis of those conditions<sup>49,50</sup>. In the most recent years, many benefits have been described from regular exercising for cardiopaths, in addition to improving functional capacity<sup>51</sup>.</p>
      <p>Exercising stands for physiologic stress on the body from the high energy demand when compared to resting, which results in high release of heat and intense change in muscular and ischemic chemical milieu. Consequently, regular exposure to exercise in the long term (physical training) promotes a set of morphological and functional adaptations that provide the body with higher capacity to respond to the stress from exercising. It is important to point out that chronic effects from exercising depend primarily on peripheral adaptation, which involves both better control and distribution of blood flow, as well as specific adaptations of skeletal musculature<sup>52</sup>. </p>
      <p>Most patients with established cardiovascular diseases refer reduced functional capacity, which is related to the reduction of VO<sub>2max</sub> obtained during ergospirometric test. Exercise capacity for those patients is determined by the complex interaction between cardiovascular, respiratory, metabolic, and muscular systems, added to autonomic nervous system modulation. Therefore, any unbalance in that interaction may reduce individual functional capacity<sup>53</sup>.</p>
      <p>The correlation between physical exercise and primary and secondary CHD prevention has been widely discussed. Results from quite a number of studies have shown the impact of physical exercise on the treatment for the condition<sup>54,55</sup>. From all those studies, two meta-analyses are to be pointed out: they have confirmed a significant reduction - from 20% to 25% - in mortality rate from cardiovascular diseases in patients that have been submitted to cardiac rehabilitation<sup>56,57</sup>.</p>
      <p>Human and laboratory animal studies have shown that shear stress (blood force on artery wall) induced by physical exercise is a powerful stimulus for the release of vascular endothelial vaso-relaxing factors, such as NO. It has been demonstrated that moderate physical training increases the relaxation of vascular and non-vascular smooth muscle resulting from higher generation of NO by endothelial cells in response to physical exercise<sup>12,58-60</sup>. Additionally, it has been observed that exercise-induced shear stress increases endothelial and neuronal NOS expression<sup>60-63</sup>.</p>
      <p>Therefore, during physical exercise, cardiac debit is increased, with blood flow redistribution to skeletal musculature and coronary circulation. That mechanism is mediated by eNOS, whose genetic expression may be potentialized with regular aerobic exercises<sup>62,64</sup>. </p>
      <p>Taddei et al<sup>65</sup> have demonstrated that physical training may prevent endothelial dysfunction through NO availability repair as a result of oxidative stress prevention. Such evidence suggests that physical exercise may prevent or attenuate the reduction of endothelium-dependent vasodilation. </p>
      <p>Therefore, the benefits from regular exercising on cardiovascular diseases are primarily associated to a higher generation of endothelium-derived vasodilating agents, with resulting reduction of peripheral vascular resistance, of LDL cholesterol levels, and platelet aggregation inhibition<sup>22,60</sup>. </p>
      <p>Results from recent studies have demonstrated that physical training provides significant myocardial perfusion improvement<sup>1</sup>. The following are among the components involved:</p>
      <p><italic>1 - Endothelial function - </italic>Frequent increase of transmural pressure in blood flow resulting from repeated exercise results in endothelial function improvement, thus contributing for easier myocardial perfusion. Such vasodilating mechanism - mediated by endothelial action - has been referred to as one of the main vascular adaptations from physical training<sup>49,59,62,66</sup>. Animal studies elsewhere have also demonstrated endothelial vasorelaxing factors resulting from physical exercise<sup>60</sup>.</p>
      <p><italic>2 - Nitric oxide synthesis and degradation velocity - </italic>In an attempt to make up for the formation of peroxinitrate, vessel smooth muscle cells produce an antioxidative enzyme - superoxide dismutase (SOD) - which blocks the action of free radicals, thus reducing NO degradation. Animal and human studies have demonstrated that physical training increases the expression of that antioxidative enzyme, as well as NOS production and expression<sup>12,67</sup>.</p>
      <p><italic>3 - Microcirculation - </italic>Some studies have raised the assumption that physical training would also stimulate NO generation in microcirculation, with resulting vasodilation action; Evidence has shown that the vasodilating capacity of resistance vessels (microcirculation) is intensified after four weeks of training, which is of key relevance for myocardial perfusion<sup>59,62,63</sup>. Results from a study conducted by Yoshinaga et al<sup>68</sup> have shown that the differences between the coronary flow reserve in both abnormal and normal segments after physical training do reflect microcirculation vasodilating action. The authors believe that response to exercise in microcirculation is complex and multifactorial, also involving smooth muscles function, endothelial function, capillary density, the regression of the condition, and collateral circulation.</p>
      <p><italic>4 - Regression of atherosclerotic lesions - </italic>Studies have demonstrated that physical exercise associated to cholesterol level control (hypofat diet) attenuates coronary injury development in the long term (four to six years of exercise), and may even lead to the regression of myocardial atherosclerotic plaque<sup>69-71</sup>. The phenomenon is seen as controversial by many, but what has been left out of the discussion is the possibility of improvement in myocardial perfusion<sup>69-71</sup>. On the other hand, the benefit of physical exercise in the short term is uncertain<sup>72</sup>.</p>
      <p><italic>5 - Neoformation of collateral vessels - </italic>Animal research has demonstrated that the narrowing of coronary artery caliber induces the onset of collateral circulation. That increase in circulation is potentialized when those animals are submitted to an exercise program<sup>70,71</sup>. However, myocardial perfusion studies have shown conflicting results on the scintigraphy of coronary patients who have been submitted to a regular exercise program. In the light of the facts presented, it can be observed that physical training effect on the formation of collateral vessels is still uncertain<sup>63,68,69,73</sup>. Generally speaking, human angiographic studies have found it difficult to find evidence of collateral circulation increase in coronary patients submitted to physical exercise - which may be explained by the fact that the exam cannot identify small size collateral arteries (&lt; 100 &#181;m).</p>
      <p><italic>6 - Blood viscosity reduction - </italic>Regular physical exercise results in plasma volume increase in addition to the reduction of some plasma proteins such as fibrinogen and globulin - a process called chronic hemodilution<sup>74,75</sup>. Despite plasma volume increase, there is no consensus in regard to hematocrit reduction from chronic exercising<sup>75,76</sup>. Concurrent reduction of plasma viscosity occurs, which may reach up to 8% in endurance athletes<sup>75,77</sup>. Viscosity reduction from physical exercise has not, however, been demonstrated in coronary patients. Whether physical exercise actually affects blood viscosity in those patients remains to be proven<sup>73,78</sup>.</p>
      <p><italic>7 - Increased diastolic perfusion time - </italic>A study conducted with coronary patients submitted to a regular program of physical exercise showed basal heart rate (HR) reduction, with longer time of diastolic perfusion at rest. Again, the longer time in diastolic perfusion was shown at exercise peak, thus attenuating the ischemic manifestations on the ECG<sup>63,79</sup>. </p>
      <p>Therefore, it is clear that physical exercise improves physical performance, tolerance to exercise, and symptoms in coronary artery disease patients, and reduces mortality rate. However, the biochemical mechanisms though which those benefits are established have not yet been fully understood. Although endothelial function improvement is the earliest phenomenon (within 4 to 6 weeks) in coronary flow increase in trained individuals, it is too early to say that this is the only mechanism involved in myocardial perfusion improvement<sup>1,68</sup>. </p>
      <p>
        <bold>Final considerations</bold>
      </p>
      <p>In the light of what has been presented, it is clear that oxidative stress does play a role in the genesis and development of cardiovascular diseases, among them, coronary artery disease. From the many therapeutic interventions used to treat those conditions, physical exercise stands out as a key tool for the maintenance and/or recovery of endothelial function. The benefits from physical exercise have been extensively documented in current literature.</p>
      <p>However, further studies are required to shed light on all mechanisms involved in that therapeutic action, as well as to sponsor an analysis of the most appropriate level of physical training for those patients, to serve as guidance to the professionals working on the prescription and orientation of physical exercise for cardiovascular disease patients in the attempt to reduce the prevalence of the condition in world population. </p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>This study was partially funded by Mutrimental SA and CNPq</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Mar&#237;lia Costa de Ara&#250;jo, from <italic>programa de p&#243;s-gradua&#231;&#227;o em Ci&#234;ncias da Sa&#250;de da UNESCO</italic>.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
</article>
